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Abstract 
Kevin Patrick Herlihy 
Shape and Size Specific:   
Fabrication, Characterization, and Application of Highly Tailored Biocompatible Hydrogel 
Particles for Use in Materials and Biomedical Settings 
(Under the direction of Joseph M. DeSimone) 
 
 This work details the method development of a bench top process designed to 
fabricate highly defined particles of uniform shape and size.  In this method, perfluorinated 
elastomeric molds were patterned off of etched silicon wafers and other substrates.  These 
molds were then filled with a pre-particle solution that was subsequently solidified by UV 
photoradical initiated polymerization.  Particle harvesting by physical agitation and a variety 
of sacrificial adhesive layers was examined.  Purification of particles was also explored using 
multiple techniques including: centrifugation, dialysis, and a variety of filtration techniques.  
Regioselective chemical and metallic surface functionalization was demonstrated.  Direct 
particle analysis was performed using microscopic techniques and indirect analysis of 
particle loading and surface chemistry was performed using spectrophotometric, 
fluorescence, and mass spectrometry techniques. 
 Micron scale particles were fabricated with a variety of shapes, sizes, chemistries, and 
cargos for materials applications.  It was determined that particle shape dictated how particles 
with an induced dipole moment aligned and crystallized in alternating electric fields.  Control 
over chaining and alignment with respect to particle orientation was gained when particles 
were loaded with superparamagnetic cargo.
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 Nanometer scale particles with different form factors were also fabricated for in vivo 
imaging and biodstribution studies in small animals.  The particles ranged in size from 80 nm 
to 2000 nm in length.  Particles were surface modified with poly(ethylene glycol) for 
protection from the reticuloendothelial system.   The particles contained or were surface 
modified with one or more contrast agent including near infrared fluorescent dye, iron oxide 
nanoparticles (for Magnetic Resonance Imaging), or Cu64 for Positron Emission 
Tomography.  This research laid the groundwork for future experiments in targeted delivery 
of therapeutics to tumors using the template based particle fabrication technology. 
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Section 1: Particle Fabrication Methods Using the Particle Replication In Non-wetting 
Template (PRINT) Technique 
 
1.1 Overview of Particle Fabrication 
 
Colloidal particles, those particles with an average diameter of 10 micrometers or 
less, have been studied in detail for varied applications in catalysis, electronics, 
photovoltaics, coatings, cosmetics, smart fluids, therapeutics, and diagnostics among others.  
While the vast majority of colloidal particles are spherical in nature, nonspherical, or 
anisotropic particles, have potential to lead to advancements in all of these applications and 
more.  Anisotropic colloidal particles, for example are capable of assembling into structures 
which are distinct from the hexagonal close packed arrangements favored by spherical 
particles and are of interest in the fields of memory storage, optical electronics, photonics and 
sensors (see Section 2).1, 2  
Anisotropic colloidal particles are exciting, however, not only because of the changes 
in optical, electrical, and other material properties, but also because of a wealth of 
advantageous biomedical properties.  Precisely designed biodistribution profiles, for 
example, are highly sought after and it is believed that shape specific colloids may hold the 
key.  In addition, enhanced tissue targeting and the ability to tote biologically relevant cargo 
such as therapeutics or imaging agents make the study of these particles very intriguing. 
 Considerable effort has been devoted to the development of fabrication methods that 
can produce colloidal particles with fine control over size, shape, composition, cargo 
	   2	  
and surface chemistry.  A number of different approaches towards particle fabrication are 
briefly reviewed in this section with an emphasis on the control over shape and size that each 
different technique is capable of.  One technique in particular, the Particle Replication In 
Non-wetting Templates (PRINT®) method is highlighted as an ideal method for the 
fabrication of monodisperse colloids with precise control over the size, shape, material 
composition, and surface chemistry of the resulting particles.  The varying aspects of PRINT 
are detailed below; from master and mold fabrication steps that lay the foundation of the 
process all the way to finishing touches of particle fabrication including purification and 
stability measurements.  This section is a summary of lessons learned in particle fabrication 
and is designed to provide a detailed snap shot of the ever-evolving PRINT process. 
1.1.1 Bottom-Up Approaches to Particle Fabrication 
 
 Two broad approaches are amenable for the fabrication of anisotropic particles: 
bottom-up and top-down techniques.  Bottom-up approaches begin at the atomic or 
molecular scale and build up to the desired particle size, while top-down methods process a 
material on the desired size scale.  The most commonly employed methods for the 
production of mass quantities of particles on the colloidal length scale are bottom-up 
synthetic approaches such as emulsion polymerization.  In a typical process, a monomer is 
emulsified via rapid stirring in a mobile phase that contains an initiator and a surfactant.  
Upon heating to activate the initiator, spherical particles are nucleated in the surfactant 
micelles and grow to the desired size.  Particles obtained by emulsion methods are typically 
spherical and can vary in size from tens of nanometers to several microns in diameter.  The 
particle size and the molecular weight of the polymers formed in emulsions are controlled 
with parameters such as the surfactant concentration and reaction temperature. Surfactant 
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adsorbed onto the surface of these particles can be difficult to remove if undesired.  While 
this method is extremely scalable, the particles fabricated in this way are typically spherical 
in shape, can have large polydispersities and are limited in chemical composition. 
 Particles with non-spherical shape are of increasing interest for biomedical 
applications such as drug delivery, where the rod-like or corkscrew morphologies possessed 
by many viruses and bacteria are suspected to have derived an evolutionary advantage from 
their specific shapes.3  Crystals of many metals and metal-oxides can be grown into both 
spherical and anisotropic shapes such as cubes, rods, discs and faceted polyhedra using 
nucleation and arrested growth strategies.1, 4, 5  More complex branched structures can be 
formed by sequential growth of dots and rods of different materials.6 Such nucleation and 
growth methods are limited to inorganics and the shape selectivity is highly dependent on the 
material and its crystal structure.  Further, these inorganic materials often lack the capability 
to encapsulate a cargo or undergo surface modification.   
 Bottom-up approaches for the fabrication of organic particles have received a great 
deal of attention for use in biomedical applications such as imaging, gene or drug delivery.  
These methods chiefly rely on self-assembly of amphiphilic molecules to create micelles, 
vesicles, liposomes, and polymersomes.  The hydrophobic interior is able to encapsulate a 
hydrophobic cargo.  While spherical particles have been the standard, increasing attention 
has been directed towards higher aspect ratio particles (particles that are taller than they are 
wide) that are achievable with control of the relative length of hydrophobic and hydrophilic 
domains.3, 7-9   
An example of high aspect ratio particles was recently demonstrated by Discher, et. 
al. who explored filamentous polymersomes called filomicelles for their circulation 
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persistence and ability to encapsulate and deliver chemotherepeutics.  The filomicelles were 
prepared from block copolymers with lipid-like amphiphilicity, but a more symmetric ratio 
of hydrophilic to hydrophobic blocks than is found in lipids.  These filamentous particles 
persisted in the circulation about ten times longer than spheres with similar surface 
chemistry, and were successful in encapsulating and delivering a hydrophobic 
chemotherapeutic to tumored mice.9  One criticism of these self-assembled systems is the 
dynamic nature of the particles so assembled.  With membrane components held together 
with attractive forces rather than with covalent bonds, the structures generated can add or 
lose components, making their size and shape more fluid than may be desired.   The dynamic 
nature of these self-assembled systems has been addressed by Wooley et al. with shell-cross 
linked knedel-like particles (SCKs).10-13  These block copolymer micelles are modified with 
reactive groups on the surface which can be chemically cross-linked after self-assembly, 
giving superior stability to their structure.   
1.1.2 Top-Down Approaches to Particle Fabrication 
 
 Top-down approaches to particle fabrication rely on tools, rather than surface energy 
and thermodynamics like so many bottom-up approaches, to tailor the size and shape of 
particles.  “Crude” top-down methods are popular in the fabrication of bulk materials.  
Examples of this include milling and grinding in which particle size distributions are highly 
disperse and shape is very irregular.  Sorting for particle size is possible using a variety of 
techniques including sieves and fractionation.  A number of new top-down techniques have 
been developed that offer substantial benefits in the control over size and shape.  Examples 
of these techniques include template based, microfluidic, mechanical stretching, and 
photolithographic approaches.  
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1.1.2.1 Hard-Template Approaches to Top-Down Particle Fabrication 
 
Hard-template methods have been used to prepare nanowires, nanotubes and 
nanorods.14-17  In this technology, porous templates are filled with one or more materials to 
fabricate monodisperse nanoparticles.  Traditionally, the templates are filled via 
electrochemical means.  This is accomplished by first depositing a sacrificial metal layer, 
such as gold or silver, on one side of the template for electrical contact. Then, the material or 
materials of interest are electrochemically deposited into the pores of the template.  For 
example, metals can be synthesized using the appropriate electroplating solution, and 
conducting polymers can be synthesized via oxidative polymerizations. After deposition, the 
template is dissolved yielding an ensemble of nanoparticles connected at the base to the 
substrate metal.  The connecting sacrificial metal layer is then dissolved to generate a 
monodisperse suspension of high aspect ratio nanoparticles.  Both tubes and solid wires or 
rods can be prepared depending on the surface treatment of the template.18  One major 
advantage of the template method is that segmented or multicomponent nanoparticles can be 
fabricated in a rational fashion (Figure 1.1).19, 20  This has led to an impressive breadth of 
research into the area of post-fabrication modifications of segmented nanoparticles.21  
Multicomponent nanorods can be selectively functionalized for different multiplexing, 
sensing and self-assembly applications.21, 22 23, 24 




Figure 1.1.  (A) General scheme for nanorod synthesis via the deposition of materials into a 
nanoporous template,19 (B) Bright-field optical micrographs of Au/Pt/Au rods,22 (C)  SEM 
images of Au-Ni multisegmented nanorods,23 and (D) SEM image of Au-polypyrrole rods.20 
 
1.1.2.2 Microfluidics Approaches to Top-Down Particle Fabrication 
 
 One emerging strategy for the fabrication of particles with control over particle size 
and shape is fabrication with microfluidic devices.  In early microfluidic particle fabrication 
studies, the shapes produced in these channels were limited to spheres, cylinders and 
spherically derived shapes such as discs and ellipsoids. More complex and chemically 
anisotropic shapes such as hemispheres25, core-shell25 and janus particles26 were produced by 
confining the droplets with the geometry of the device and with coflowing laminar streams, 
though these remain derivatives of the original spherical shape.  Recently, the Doyle group 
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has developed photolithographically coupled approaches, which have produced more 
complex shapes by use of a photolithographic mask.27, 28  Particles were crosslinked by the 
UV light exposure almost instantaneously, and did not plug up the channel due to the oxygen 
mediated inhibition of polymerization at PDMS surfaces, which left a thin layer of 
unpolymerized monomer at the channel walls.29  Exposures across several fluid streams 
resulted in the formation of janus type particles with two or more chemically distinct regions 
on each particle.27, 30  Higher resolution has been achieved with the use of stop-flow 
lithography (SFL), a process during which the flow of monomer was stopped briefly during 
each exposure.  Complex shapes have been formed with high resolution in the micron scale, 
including a range of concave and convex sided pyramids, rectangles, and spheres, and 
rectangular toroids - all with multiple, chemically distinct phases possible.28, 31   
 Microfluidic methods have demonstrated their versatility in terms of particle shape 
and chemical anisotropy of the particles produced (see Figure 1.2).   The emergence of SFL 
techniques have increased the resolution of this technique though there are material 
limitations; particles made in this way have been limited to polymerizable fluids and 
selection of the mobile phase has been limited due to the swelling of the device material, 
PDMS, in many solvents.  Another limitation has been the size of particles which can be 
produced with these methods.  Particles on the order of 3-100 µm were readily fabricated, but 
sub-micron particle sizes remain a challenge for microfluidic technology.  
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Figure 1.2.  (A)  Illustrations of the three main microfluidic geometries used for droplet 
formation,32  (B)   A schematic used for continuous-flow lithography and (C) microparticles 
of varying shapes fabricated with this method,27  (D)  Right:  A schematic for the channel and 
flow configuration used for the formation of the bicolored janus particles shown on the left.33 
 
1.1.2.3 Mechanical Stretching as a Top-Down Approach to Particle Fabrication 
 
 One relatively new method for the fabrication of shape and size specific colloids 
relies on the mechanical stretching of spherical particles.  Particle stretching was initially 
used to deform polystyrene (PS) particles that were embedded in a polyvinyl alcohol (PVA) 
film.  Upon heating to a temperature at which the particles could deform, the film was 
stretched, then rapidly quenched, yielding ellipsoidal particles upon dissolution of the PVA 
fim.34  Recently, Champion et. al. reported the formation of complex shapes via a similar 
method (Figure 1.3).  In this method, as before, (PS) particles were embedded in a PVA film.  
The PS particles were liquidized by addition of heat or solvent, allowing the PS to flow, 
filling void spaces in the surrounding film, or to stretch with the film due to hydrogen 
bonding based attraction to the surrounding film.  Manipulation of the PS particles required 
exposure to temperatures on the order of 140 ºC or organic solvents (toluene), which places 
some limits on the encapsulation of cargos by these particles.  Careful modifications to the 
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stretching protocol allowed for selective formation of over twenty distinct particle shapes 
upon solidification of the particles by cooling or removal of solvent and subsequent release 
from the PVA film.35   
 One distinct advantage of the particle stretching technique has been the ability to 
compare differently shaped particles with identical volumes by preparing different particle 
shapes from the same stock of spherical particles.  Material compatibility is a concern for this 
method, as the bulk of the literature deals with PS and poly(lactic-co-glycolic acid) (PLGA) 
based particles – though one can imagine that many materials could be manipulated in this 
way by adjusting the conditions used to fluidize the particles and the material in which the 
particles are embedded.  This method is versatile with respect to particle size, as spherical PS 
particles with diameters from 60 nm to 100 µm have been subjected to these stretching 
protocols.   Polydispersity of the particles prepared by stretching methods was reflected by 
the polydispersity in the spherical particles before stretching.  Careful selection of a spherical 
particle source could lead to the formation of more monodisperse populations of stretched 
particles.   
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Figure 1.3.  (A)The two general schemes used in stretching spherical particles to different 
shapes.  In Scheme A, particles are liquefied prior to stretching the film, while Scheme B has 
the film stretched prior to particle liquidification. (B)  Polystyrene particles prepared via the 
method shown in scheme A. (C) Polystyrene particles prepared Scheme B.35 
 
1.1.2.4 Photolithographic  Approaches to Top-Down Particle Fabrication 
 
Photolithography, the workhorse of the semiconductor industry for high volume 
manufacturing36, 37, has also been directly applied to the fabrication of discrete monodisperse 
colloidal particles.38-41  A simple illustration of this process is shown in Figure 1.4A.  Both 
Mason et al.39 and Stroock et al.42 have reported using this type of approach to generate 
highly monodisperse, shape-specific colloidal particles.  Stroock et al.43 demonstrated the 
ability to tailor the surface roughness of the particles by modifying the development 
conditions (Figure 1.4 B).  Mason et al.39 illustrated the shape versatility of this process by 
generating particles with a wide range of shapes (Figure 1.4 C), including all 26 letters of the 
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English alphabet.   The fabrication of the lithographically-derived particles, or LithoParticles 
as coined by Mason, was also found to be amenable to the incorporation of both organic dyes 
and nanoparticles such as iron oxide.  It was even feasible to fabricate hybrid bilayer Janus 
particles, through the successive exposure of two different masks. 
Clear advantages of this type of processing include excellent shape fidelity down to 
the submicrometer level and the ability to fabricate particles in a high throughput fashion.  A 
major stumbling block for using this process is the enormous capital required to continuously 
run such an expensive lithographic exposure system.  Another issue with this type of 
processing is the limitations in the chemistries that can be used in the particle fabrication.  
These issues have led to the development of alternative routes to LithoParticle production 





Figure 1.4.  (A) Simple scheme showing the photolithographic fabrication of colloidal 
particles,42 (B) Cylindrical photoresist particles engineered with rough side walls (particle 
radius = 520 nm, height = 875 nm),43 (C) Photoresist particles of varying shapes (scale bars 
represent 3 µm): square donuts, square crosses, triangular prisms and pentagonal prisms 
(from top to bottom),39 and (D) 4-valent and 6-valent nanoparticles fabricated using 
interference lithography (scale bars represent 300 nm).40 
 
1.1.2.5 Imprint Lithography Approaches to Top-Down Particle Fabrication 
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 Imprint lithography based methods have emerged in recent years as promising 
techniques for scalable fabrication of shape specific colloidal particles.  Soft lithography 
based techniques, which were pioneered by Whitesides et al. in the late 1990’s, begin with 
the use of a rigid template which is used to fabricate an elastomeric mold, which can then be 
used to replicate the shape of the original template in a molding or stamping process.46  
Imprint methods were first envisioned as a high-resolution, low-cost alternative to traditional 
photolithograpic techniques for micro- and nanoscale pattern replication rather than 
fabrication of distinct particles.  Particle fabrication has been a challenge due in large part to 
the persistent formation of a residual layer of molded material, called a flash layer, which 
connects the potential particles.47  Much attention has been directed towards the removal or 
avoidance of this flash layer with the goal of particle fabrication.  Step and flash imprint 
lithography (S-FIL) uses a rigid, UV transparent template as a mold material, creating an 
embossed film of particles from a UV curable material.  The interconnecting flash layer is 
removed by an etching step, with dissolution of a sacrificial layer yielding distinct 
particles.48, 49  Removal of the flash layer via an oxygen plasma etch can be energetically 
expensive and time consuming. 
 Soft lithography applications that utilize crosslinked poly(dimethyl siloxane) (PDMS) 
elastomer, typically result in particles connected by a flash layer.  Recently, microparticles 
were fabricated with PDMS molds without formation of a flash layer by careful applications 
of photocurable acryalte resins, as well as aqueous and organic solutions of polymers, to the 
molds.50  Surface treatments were shown to increase or decrease the hydrophilicity of the 
mold, facilitating mold-filling, mold de-wetting, and particle release.51, 52  PRINT technology 
(Figure 1.5), which utilizes a fluorinated elastomeric mold in an imprint lithographic 
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technique, allows for facile fabrication of distinct particles without formation of a flash layer 
while maintaining many of the advantages of the soft lithography technique and avoiding 
some of the difficulties associated with PDMS.53 
 
 
Figure 1.5:  A general schematic representation of the PRINT process.  (A) A pre-particle 
solution (red) is distributed evenly in the elastomeric mold (green) by a roller (black) with a 
high surface energy polymer sheet, which wicks away excess solution.  (B) The particle 
solution is solidified in the mold.  (C) Particles are removed from the mold with a harvesting 
film (yellow). (D) Dissolution of the film yields free flowing particles in solution. 
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1.2 Particle Replication In Non-wetting Templates (PRINT)   
 
1.2.1 PRINT Overview 
 
In 2004, Rolland et al. reported the synthesis of a new perfluoropolyether (PFPE) 
based elastomer54, a material that proved to be more effective than PDMS as a template for 
soft lithography based particle fabrication.  Photocurable PFPE (FluorocurTM, Liquidia 
Technoligies Inc., NC) was synthesized by endcapping a fluorinated PFPE diol (Solvay) with 
isocyanatoethyl methacrylate to form PFPE dimethacrylate.  The end-functionalized 
fluorinated oil had a positive spreading coefficient allowing it to completely wet and 
envelope the delicate details of a master template.  Curing of the oil was accomplished under 
UV light (365 nm, ~10-15,000 mJ/cm2) after the addition of a photoinitiator. The resulting 
PFPE elastomers have three distinct advantages over silicone templates for use in soft 
lithography.  First the low surface energy of the elastomer (8-10 dyn/cm)55 facilitates the 
removal of an excess flash layer.  Other lithographic methods typically require an etch step to 
remove this layer, complicating the scale up of these methods.46, 56  Second, PFPE was 
observed to be compatible with a number of organic solvents that were incompatible with 
silicone molds.54  It was found that, while both Sylgard 184 (a silicone material) and PFPE 
molds exhibited negligible swelling in the presence of water and methanol, Sylgard 184 
molds were permeable to toluene and dichloromethane. An examination of several other 
common solvents and polymerizable organics showed a similar trend, with PDMS coupons 
generally showing a higher retention of these organic fluids (table 1.1).  With the elimination 
of swelling, master-to-replica fidelity was improved and the reproduction of much smaller 
feature sizes was possible.  In 2006, Maynor et al. showed that a variety of nanoscale 
artifacts could be reproduced using the PRINT technique including 60 nm adenoviruses, 45 
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nm polymeric toroidal micelles, and single walled carbon nanotubes with heights as low as 2 
nm.55  Third, the highly fluorinated nature of the mold (similar to that of TeflonTM) facilitated 
the removal of particles from the mold.  In contrast, other soft lithography methods required 
surface modification of the molds to facilitate particle removal.51, 52 A number of published 
manuscripts are available describing a wide variety of particles fabricated using the PRINT 
technique (Figure 1.6)8, 53, 57-64 
Table 1.1.  A comparison of swelling behavior, reported as the percent increase in weight of 
coupons of crosslinked elastomeric materials after soaking overnight.  Traditional soft 
lithography mold material, poly (dimethylsiloxane) (PDMS), and PRINT mold material, 




(weight % uptake) 
PFPE 
(weight % uptake) 
Water 0.37 ± 0.04 0.39 ± 0.16 
Hexane 109.82 ± 1.41 1.72 ± 0.25 
THF 145.46 ± 1.68 6.95 ± 0.08 
DMSO 2.36 ± 0.50 1.98 ± 0.17 
Isopropanol 17.65 ± 2.44 2.38 ± 0.06 
Acetone 20.15 ± 1.05 4.81 ± 0.06 
Poly (ethylene glycol) methyl ether 1.04 ± 0.45 0.36 ± 0.07 
2-hydroxyethyl acrylate 1.45 ± 0.23 1.03 ± 0.22 
N-Vinyl-2-pyrrolidone 5.55 ± 0.31 2.34 ± 0.27 
PEG  triacrylate  1.40 ± 0.06 0.31 ± 0.05 
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Figure 1.6. Illustrative examples of size, shape, composition, cargo and surface chemistry 
control with the PRINT process (A-B) 80 nm x 2000 nm worm-like cross-linked 
poly(ethylene glycol) (PEG) nanoparticles on a harvesting layer, inset showing AFM image 
of harvested layer, (C) 10 wt. % iron oxide-loaded 200 nm cylindrical cross-linked PEG 
particles, (D) siRNA-loaded 200 nm albumin nanoparticles harvested onto a medical 
adhesive, (E) boomerang-shaped cross-linked PEG microparticles, (F) hexnut-shaped cross-
linked PEG microparticles on a cyanoacrylate harvesting layer, (G-I) 2x2x6 mm cross-linked 
PEG rectangular prisms showing increasing chemical anisotropy: (G) one-phase, (H) 
biphasic, and (I) triphasic. D62 and H, I.66 
 
1.2.2 Master Fabrication 
 
 Typically, patterned silicon wafers were used as masters from which a pattern is 
transferred to a PFPE mold.  Fabrication of silicon masters was performed using standard 
photolithographic instrumentation and techniques.  In its most basic form, photolithography 
is a process in which a thin film of photoresist on a silicon wafer is exposed to light that has 
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passed through a patterned reticle.  The light induces a change in solubility in the photoresist.  
In a positive photoresist, whatever is exposed becomes soluble.  This change in solubility is 
typically due to the cleavage of a photoacid generator group pendant to the backbone of the 
polymer.  In negative photoresists crosslinking occurs upon exposure to light that eliminates 
the ability to dissolve the exposed regions.  After exposure and removal of the soluble 
portion of the photoresist, one of any number of etching processes can be used to etch the 
silicon.  Finally, cleaning steps are used to remove residual photoresist from the wafer.  
Achievable feature sizes for each technique are largely dictated by the wavelength of light 
that is used to expose the photoresist. 
 Patterned masters with micron scale features were fabricated at the Cornell Nanoscale 
Science and Technology Facility (CNF).  Briefly, 4 x 4” chrome on glass reticles (50 mm 
field size) were either fabricated using a Heidelberg DWL66 Mask Writer or they were 
purchased from Holographix, LLC.  Feature sizes in the reticle were 5 times the size of the 
desired features of the master.  Wafers were cleaned with 1:1 NH4OH:H2O2 then with 1:1 
HCl: H2O2 and were rinsed with d.i. water and dried (a process known as metal-oxide 
semiconductor (MOS) cleaning).  Wafers were then primed for photoresist with hexamethyl 
disylazane (HMDS) using a YES LP-III vacuum oven.  Next, the wafers were placed in a 
Brewer Science CEE Model 600 and were coated with SPR 220-3.0 photoresist which was 
spun cast at 5000 rpm for 60 seconds.  The wafers were baked at 115 °C for 60 seconds to 
remove residual solvent then cooled to room temperature.  Photoresist along the edge of the 
wafer was removed to facilitate later etching steps.  After edgebead removal, micron scale 
feature sizes (0.5, 1, 2, 3, 5, 7 and 10 µm) were exposed into photoresist using a GCA 
Autostep 200 DSW i-line (365 nm laser) wafer stepper with a 5 x reduction lens.  The 
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exposed photoresist was then developed with 300 MIF developer for 60 seconds using a 
Hematech-Steag Wafer Processor.  An O2 plasma clean was then performed to remove 
excess photoresist.  To etch the silicon, a Bosch Etch procedure was employed using a 
Unaxis 770 couple plasma/reactive ion etcher.  The etching process used C4F8, SF6, and Ar 
gases for an etch rate of 1 µm/minute.  Finally, any residual photoresist was removed from 
the wafers in a two part process involving first, a two tank hot resist strip bath/rinse/dry cycle 
and second, a 15 second oxygen plasma removal cycle a Branso P2000 barrel etcher.  Silicon 
masters were characterized by SEM.   
Masters with smaller feature sizes (< 500 nm) were provided by Liquidia and were 
typically made using 193 nm photolithography technology.  Other lithographic techniques 
with even higher resolution are available.  E-beam photolithography for example, is capable 
of creating 10-20 nm feature sizes.  Anoter technique using self assembled block copolymer 
masters have been shown to be effective in highly regular feature sizes smaller than 20 nm.67 
1.2.3 Mold Fabrication 
 
 Initially, mold fabrication was performed by drop casting 20-30 mL of Fluorocur 
resin onto a 6-8 inch diameter patterned silicon master template that was then cured 
photochemically in a UV oven.53  Molds were released from the template by slowly peeling 
them back from silicon wafer using PTFE tweezers so as not to scratch the fragile surface 
features.  Because of the delicate nature and the high cost associated with using large 
quantities of Fluorocur Resin for the thick molds, the scale of particle production was 
limited.  With this in mind, a proprietary roll-to-roll system capable of producing thousands 
of linear feet per day of PFPE molds on a flexible poly (ethyleneterephthalate) (PET) 
backing, was recently engineered by Liquidia Technologies, Inc.  The new process yields 
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more mechanically robust molds and reduces the Fluorocur resin requirements by several 
orders of magnitude making the process more time effective, less costly, and highly scalable. 
 Thin molds have also been successfully fabricated in the lab.  Typically, a 500 µL 
aliquot of Fluorocur is gently spread over a silicon master using a sheet of PET specially 
treated for adhesion with PFPE.  Air bubbles are removed from between the master and the 
PET by peeling the PET all the way off of the PFPE-wetted master surface and gently rolling 
the PET back over the master using a small hand roller.  The master/PFPE/PET sandwich is 
then placed in a UV oven which is then purged of O2 using N2.  The mold is cured for 3 
minutes and allowed to cool to room temperature.  The mold is then gently peeled off the 
master revealing a clean mold bound to a PET backing sheet. 
1.2.4 Mold Filling 
 
 Filling of any patterned mold is a process that relies heavily on surface energies of the 
materials in play.  In order to effectively fill the cavities, a pre-particle solution should have 
the ability to partially wet the surface of the mold.  Solutions capable of wetting the surface 
of a mold are drawn into the mold cavities by capillary forces.  At this point excess pre-
particles solution covers the entire surface of the mold in what is referred to as a flash layer.  
Excess pre-particle solution was removed by first laminating the filled mold with a high 
surface energy material (i.e. PET, surface energy = 42.1 mN/m)68 and second, peeling back 
the laminate material.  Capillary forces trap the liquid in the mold while excess solution 
adheres preferentially to the high surface energy material and is wicked away, leaving 
isolated reservoirs of pre-particle solution, thus eliminating the need for a scum removal step. 
 Film thickness of the pre-particle solution, like surface energy, also plays an 
important role in effective large scale particle fabrication. Films that are too thick make the 
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removal of excess solution difficult and often lead to the formation of scum.  Films that are 
too thin lead to patchy filling or shortened particles.  As such, uniform films were drawn on a 
PET sheet using a metal Mayer rod with grooved surface features and a mechanical film 
coating instrument (R.D. Speicialties Inc).  Film thickness was dictated by both the grooved 
feature size of the Mayer rod and the concentration of the pre-particle solution.  Best results 
were observed when the film thickness was on the order of the feature height of the mold.  
For example, a 200 nm tall particle would fill best with a 200 nm film.  In addition, it was 
determined that performing the filling and splitting steps in one continuous movement 
provided the best results. 
 Unlike patterning on a solid substrate, or with a rigid patterned template which can be 
time consuming, patterning of the pre-particle solution can be done in a continuous fashion 
when the template and pre-particle solution are both on flexible backing.  Other particle 
fabrication methods like S-FIL involve a step by step procedure in which a master template is 
brought into contact with a solid substrate in the presence of a pre-particle solution, a step 
that can damage the master template if performed without care.  In the PRINT process, after 
a uniform film was cast on PET as described above, the PET was laminated to an empty 
mold using an in-house single-nip lamination system.  Lamination conditions (pressure, 
speed, temperature, and humidity) were optimized for each new class of particle.  Monomer-
based pre-particle films that flowed freely into the cavities of the mold and had low vapor 
pressure were laminated at room temperature.61  Volatile monomers and other small 
molecule systems required that the lamination temperature be reduced and that the lamination 
take place in glove bag or other controlled environment.  Polymeric films like PEG or PLGA 
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sometimes required heat to raise the temperature of the film above the glass transition 
temperature of the polymer allowing the polymer to flow into the mold. 
1.2.5 Particle Curing and / or Solidification 
 
 While the majority of “Top Down” particle fabrication processes rely on 
photochemical curing, particle solidification using the PRINT technique can be quickly 
accomplished by a variety of different methods.  Monomer systems incorporating a small 
amount (~ 1 % or less) photochemical initiator such as 1-hydroxycylohexyl phenyl ketone or 
2,2-diethoxyacetophenone (HCPK and DEAP, Aldrich) were cured in a UV chamber.63  
Some monomeric pre-particle systems that were sensitive to light were instead cured 
thermally using a temperature sensitive initiator such as 2,2-bis-azobutronitrile (AIBN, 
Aldrich).  Polymeric systems cast from a solvent were dried and solidified under vacuum 
while neat polymeric systems were dropped below their glass transition temperatures causing 
them to become glassy and solid.  Small molecule and protein based “biological” systems 
that were cast from a solution were typically lyophilized.62  
Particle solidification, regardless of the chemical process of solidification, was 
typically performed either closed-faced, with a PET sheet laminated to the surface of the 
filled mold or open-faced69 with the filled mold exposed to a N2 purge.  Solidified particles 
trapped in the mold or bound to a harvesting layer of PET could be harvested immediately or 
wound up and stored until harvesting at a later date. 
1.2.6 Particle Harvesting 
 
In early particle fabrication experiments using the PRINT method, removing particles 
from the mold was initially performed by physical agitation of the particles with the sharp 
end of a glass slide.59  A number of problems were associated with this harvesting technique.  
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First, this method was found to damage the surface of the molds creating large chunks of 
PFPE mold that would have to be filtered out later.  Second, scraping dry particles could 
cause them to aerosolize.  And third, the harvesting process was not scalable.  With the 
introduction of thinner molds from, scraping caused even more damage to the molds than 
with the thick PFPE molds because there was less elastomeric material to dampen the force 
of the scraping glass edge. 
As a result, new harvesting techniques were developed that were more gentle, safe, 
and scalable.  If solidified with an open face as noted above, the particles in the mold could 
be laminated to an adhesive layer such as poly(vinyl pyrrolidone) (PVP) or cyanoacrylate on 
a flexible or rigid backing such as PET or glass slides.  Once the adhesive solidified, the 
mold was peeled away from the substrate revealing an array of free-standing particles.  The 
adhesive was then dissolved and the particles collected in solution.  This method was found 
to be especially useful for larger micron scale particles that required the strength of 
cyanoacrylate to be removed from the mold.   
While this method appears straightforward in its implementation, it can be difficult to 
successfully harvest particles in this manner.  The reasoning behind this, is that particles are 
strongly trapped within the cavities of the mold by capillary forces and Van der Waals 
interactions with the PFPE.  As a result a great deal of force is required to remove the 
particles from the mold.  This means that any adhesive used to perform this task needs to 
have strong interactions with the surface of the particle.  Therefore the sacrificial adhesive 
layer needs to be chosen with each particle’s surface chemistry in mind.  Hydrophilic 
particles should be harvested with hydrophilic adhesives etc.  
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If the particles were solidified with a closed face (laminated to PET), the particles 
adhered to the raw PET once the mold was peeled back.  This works well for particles that 
are hydrophobic in nature (ie. triacrylate or poly(styrene)-co-poly(butadiene)).  For particles 
that are more hydrophilic (ie. particles with long PEG chains or charged monomers), the 
surface energy of PET was readily increased through the process of corona surface treatment.  
Pre-treated PET sheets (Melinex 453) were also used for higher surface energy removal of 
hydrophilic particles.  Caution here is necessary as curing particles in the presence of a 
surface that is too similar in nature can lead to irreversible binding of the particles to the 
surface.  Once removed from the mold, free-standing particles that are physisorbed to a sheet 
of PET can be harvested by lamination to another adhesive layer or by physical agitation 
with a soft rubber cell scrapper in the presence of a solvent. 
1.2.7 Particle Purification 
 
Regardless of the fabrication method, after harvesting, particles made from “Top-
down” techniques generally require some form of purification to remove debris or residual 
compounds from the fabrication process, and also to prepare particles for their intended use.  
As mentioned above, when using AAO as a template, particle fragmentation often 
occurred.70   Even particles that only required minimal manipulation by physical stretching 
on a sheet of PVA required multiple rinsing steps to remove excess PVA from solution.35  
Fortunately, a wide variety of purification methods are currently available and it is usually 
possible to find at least one method that fits well with a particle fabrication technique. 
Dialysis (>100,000 MWCO, Float-a-lyzer, Spectrum Labs, Inc) was originally used 
for PRINT particle fabrication to remove impurities such as sol fraction and to exchange 
buffer solutions.  This method was found to be a relatively slow and ineffective process 
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because particles were often physisorbed to the membrane surface.  In a typical purification, 
spent solvent had to be switched for clean solvent at least three times over the course of 1-2 
days. 
Centrifugation is perhaps the simplest method of particle purification and it is used 
widely as a quick method to rinse particles and separate various sized populations of particles 
gravimetrically.58  In centrifugation, particles are spun out of solution under high centrifugal 
forces.  As particle size decreases, the centrifugal speed and the time required to effectively 
pellet out particles effectively increases.   Particle yield can be reduced when centrifugation 
is halted prematurely.  As such, purification of small stable particles, less than a few hundred 
nanometers in diameter, can be quite time consuming requiring hours or days to fully pellet a 
sample.  Other problems including irreversible aggregation may be encountered when 
particles are centrifuged for long periods (>1hr) at high speed (14,000 rpm / 20,000 G).  
Additionally, resuspending pelleted particles by vigorous mixing and/or sonication can 
damage particles composed of less robust matrix materials or with high aspect ratios as well 
as fragile cargos, such as proteins and other biologically active cargo, and should be 
performed with care. 
Centrifugal filtration using 0.1 µm cutoff poly(vinylidene fluoride) (PVDF) 
membranes (Microcon-MC, Millipore) proved to be an efficient alternative to standard 
centrifugation.  Lower speeds are required than normal filtration and therefore aggregation is 
typically reversible.  Unfortunately, once spun down, particles are partially adhered to the 
PVDF membrane.  The strength of particle adhesion to the membrane depends strongly on 
both the chemistry of the particles as well as that of the membrane.  Removal of particles 
from the membrane was found to be optimal when the membrane was physically removed 
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from its housing and sonicated in solution.  While a variety of polymeric membranes and 
pore sizes are available making this technique adaptable for a variety of particle fabrication 
methods, particle loss is often dramatic (as much as 50% loss of mass), and the batch process 
with repeated rinsing can be slow and therefore it is not ideal for high throughput particle 
fabrication. 
Filtration using indirect or tangential flow filtration (TFF) systems appeared to be the 
most promising approach for particle purification.  In TFF filtration systems such as KrosFlo 
(Spectrum Labs, Inc) particle solutions traveled tangential to the membrane.  Both 
diafiltration as well as concentration are possible without changing particles from one set up 
to another.  Particle loss by adsorption to the membrane and to surfaces was reduced as 
particles were not forced to interact directly with the membrane or multiple vials and/or pipet 
tips. Stirred Cell filtration (Millipore), another indirect filtration method, was also examined.  
While this method of purification appears promising, inadequate stirring can lead to filters 
clogged with particles creating prolonged filtration times.  Additionally, if the cell is allowed 
to run dry, dramatic loss of particle yield is observed due to irreversible adhesion of the 
particles to the filter membrane. 
Other methods of particle purification are also under development.  Magnetic 
purification for example is currently being used for particles containing magnetic cargo.  
While it was strictly limited to magnetic particles, this method, using magnetic columns 
(Minisep, Miltenyi Biotec) appeared promising for purification and other functionalized 
particle applications.  In addition to magnetic filtration, Flow Field Fractionation (FFF) is of 
interest for future purification and separation of particles as particle aggregation is not as 
prevalent as in other centrifugal techniques. 
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1.2.8 Particle Surface Modification 
 
One unique feature of template based particle fabrication is that solidified particles, 
either in the mold or on a harvesting layer of PET, are easily subjected to a number of 
regiospecific chemical modifications.66  Chemical modification of particles while in the mold 
made it possible to manipulate one face of the particle.  Once removed from the mold, 
modification of particles on a harvesting layer allowed the manipulation of the remaining 
sides of the particle.  This is an exciting development for a number of fields of research 
including nano- and microrobotics 71-73 and targeted drug delivery.66  Ongoing research in our 
lab is focused towards directed cellular uptake of regio-modified particles as well as the 
beginnings of shape-specific building blocks for directed assembly in smart fluids and 
microrobotics applications. 
1.2.10 Particle Characterization 
 
 Particles were analyzed using a number of different techniques.  Techniques for 
imaging particles included scanning electron microscopy (SEM), transmission electron 
microscopy (TEM), atomic force microscopy (AFM), optical and fluorescence microscopy.  
Surface chemistry and stability was determined using dynamic light scattering (DLS), zeta 
potential analysis, and turbidity as well as a number of other indirect assays that are 
described in detail in later sections.  Particle concentration was typically determined 
gravimetrically using a thermogravimetric analysis (TGA) instrument.  While individually, 
each method provided one or two attributes of a particular particle sample, typically a 
combination of the above characterization techniques was required to get the full picture of 
what a particle sample was.  Below are typical conditions and sample preparations for each 
characterization technique. 
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1.2.10.1 SEM 
 
 SEM was used as a method to rapidly examine particle morphology.  Particle samples 
were imaged by SEM in an array (ie. harvesting layer) or cast from solution.  When cast from 
solution, particles were thoroughly rinsed with filtered deionized (d.i.) water then drop cast in 
low (0.001 mg / mL), medium (0.1 mg / mL), and high (1-10 mg / mL) concentrations onto a 
clean glass slide.  After drying at room temperature the particles were coated using with 3 - 5 
nm gold / palladium using a Model 108 Auto Sputter Coater (Cressington Scientific 
Instruments).  Particles were then imaged using a Hitachi model S-4700 SEM at 2 kV 
acceleration voltage.  A typical SEM of 200 x 200 nm PEG-based PRINT particles is shown 
in Figure 1.7. 
 
 
Figure 1.7 Scanning electron micrograph of 200 x 200 nm cylindrical particles on a 




	   28	  
 TEM was often used to examine the loading of magnetic iron oxide into the core of 
the particle.  Samples were prepared by dipping a carbon-formvar coated TEM grid into 
aqueous dispersion of particles of varying concentrations (see above).  The samples were 
wicked dry using a piece of filter paper and allowed to dry completely at room temperature.  
Samples were then imaged as is using a Jeol 100 CX II instrument with a 40 kV acceleration 
voltage operating in bright field mode.  A typical example of a 200 x 200 nm particle with 
encapsulated iron oxide nanoparticles is demonstrated in Figure 1.8. 
 
 
Figure 1.8 Transmission electron micrograph of 200 x 200 nm cylindrical particle containing 
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 Samples were typically imaged in an array in order to determine the depth of filling in 
the mold itself or to determine the height of particles on a harvesting layer.  Samples were 
prepared for AFM by adhering a small square to the sample stage using cyanoacrylate 
adhesive which was allowed to dry at room temperature for 10 minutes.  The sample was 
then imaged using a Nanosurf Easyscan 2 AFM (Nanoscience, Inc.) in dynamic contact 
mode using an ACLA tip.  Examination of an 80 x 2000 nm patterned PFPE mold by AFM is 
demonstrated in Figure 1.9. 
 
 
Figure 1.9 Atomic force microscopy image of a patterned PFPE mold with 80 x 2000 nm 
“worm-like” surface features.  The AFM image shows that the mold is clean and free of 
defects. 
 
1.2.10.4 Particle Stability 
 
 Particle stability was determined either by dynamic light scattering or by turbidity 
experiments, a spectrophotometric technique that monitors the transmittance of light through 
a particle dispersion over time.  Samples were prepared for DLS and Zeta potential 
experiments by dilution of particles (~ 0.001 – 0.050 mg / mL) in a low concentration 
	   30	  
electrolyte (1.0 mM NaCl).  Typically, both Zeta and DLS experiments were performed at 25 
°C and could be run in the same cuvette using the Malvern Instruments Zetasizer Nano ZS 
equipped with an autotitrator.  Particle polydispersity and hydrodynamic radius were 
determined.  Low polydispersity (PDI < 0.1) and particle sizes slightly larger than the feature 
size of the mold used to make the particle indicated that the particles were stable and had not 
formed large aggregates in solution.  Particle isoelctric points were determined using this 
instrument providing crucial information on the operational pH range of the particles.   
 Turbidity was useful in determining how stable concentrated samples of particles 
were.  Particle samples (5-20 mg/mL) were prepared in 0.2, 1.0, and 5.0% (w/v) aqueous 
CTAB solutions. The particle sample in a cuvette (100 µL, QS) with a path length of 1 cm 
was then vortex mixed and placed in a plate reader (Spectra Max M5, Molecular Devices). A 
kinetic experiment was performed at 490 nm, and an absorbance reading was taken every 30 
s for 1 h at 22 °C.  All experiments were repeated three times to establish reproducibility. 
The turbidity, τ, defined as the attenuation of the light beam by scattering when passing 
through a sample, was determined from equation 1.1, where Io is the incident intensity of 
light, It is the transmitted intensity, and l is the optical path length.  See Section 3 Chapter 2 
on particle stability for an example of turbidity experiments. 
€ 
λ = l−1 ln(Io /It ) (eq. 1.1) 
1.2.10.5 Particle Concentration 
 
 Accurate particle concentration was essential for all experiments and particle 
analysis.  Therefore a rapid, effective means of particle concentration determination using 
TGA was developed.  In a typical experiment, a 25 µL aliquot of purified particle dispersion 
in d.i. water (typically cloudy to the eye) is placed in a pre-tared aluminum pan on the TGA.  
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The sample is then heated well above 100 °C (typically 130-105 °C) to drive the evaporation 
of all water.  The sample is then cooled to room temperature.  Particle concentration is 
calculated as the dry particle mass divided by the initial sample mass. 
1.3 Summary 
 
 An increase in demand for monodisperse, shape and size specific colloidal particles 
for both the academic and industrial sectors has driven the development of multiple new 
synthetic techniques for colloidal particle fabrication.  While a number of fabrication 
techniques have been shown to make such shape and size specific particles, all such methods, 
until now, have exhibited a number of inherent disadvantages.  The DeSimone Lab has 
developed a scalable platform for particle fabrication that surmounts all of these obstacles.  
The current state of the art in bench top particle fabrication using the PRINT technique was 
detailed as it was used during my studies at UNC.  Fabrication of the particles was described 
from start to finish with an emphasis on the most basic methods used for making and 
analyzing the particles.  The following sections will describe in greater detail three projects 
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Section 2: Shape and Size Specific Contrast Agent Fabrication, Characterization and 
Early Biodistribution Studies 
 
2.1 Introduction to Nanomedicine and Nanodiagnostics 
 
As new nanopharmaceuticals and nanocontrast agents are being developed, 
researchers are focusing on minimizing side effects and improving specific biodistribution 
found in their traditional small molecule counterparts.  Overcoming barriers for effective 
bioavailability of small molecule therapeutic agents has been especially challenging in the 
fields of gene therapy1 and oncology.2  As an illustration, despite their potential for wide 
application, only a few antisense oligonucleotides or small interfering RNA’s (siRNA) have 
entered the clinic.  The prevalence of hydrophobic drugs constitutes the need for 
nanocarriers; for these systems, direct dissolution in the bloodstream is limited without the 
formation of a salt or use of a delivery vector.3  One solution to this problem is the delivery 
of drugs, gene therapy agents, and imaging contrast agents via nano-scale vectors, and this 
has been an area of intense study for decades.  Although multiple approaches have been 
explored and great strides have been made in therapeutic drug delivery and diagnostic 
imaging agent carriers, a set of rules for the rational design of nanocarriers has not yet been 
fully established.  This is due in part to limited understanding of how their size, shape, matrix 
functionality, porosity, flexibility, and surface chemistry interact.  Clearly, a strong 
motivation for the development of nanocarriers exists in cases in which the drug or imaging 
agent is too fragile, insoluble, or toxic for direct in vivo administration.  
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Potential delivery solutions including liposomal pharmaceutical carriers4, 
polyplexes,5, 6 and polymer-drug conjugates,7, 8 have shown promise on several fronts for 
decades.  Indeed, the breadth and volume of therapeutic and imaging nanoparticle literature 
is considerable.  However, the development of shape and size specific therapeutics and 
imaging agents has only now begun to gain traction.  Research groups focusing on the effect 
of shape and size of nanocarriers are beginning to make significant progress towards shape 
driven biodistribution.9, 10  In this subsection, the latest advances in shape and size specific 
nanotherapeutics are briefly reviewed setting the stage for shape specific multimodal contrast 
agents.  The fabrication, characterization and initial biodistribution studies of multimodal 
shape and size specific PRINT particles are described in detail in the following subsections.   
2.2 Background on Nanotherapeutics 
 
Several critical factors that must be considered in the design of contrast agent and/or 
polymeric drug carriers include the chemical functionality and mechanical flexibility of the 
matrix, the degree of cross-linking, if any, the dispersion or encapsulation of the drug within 
the matrix, the permeability of the cargo through the matrix of the particle, the number and 
the nature of phases that comprise the particle (one phase versus two or more phases e. g. 
drug rich phase and matrix rich phase), the size and shape of the particle, and the surface 
chemistry.  Many of these factors have been varied extensively as imaging contrast agents 
and therapeutic cargos ranging from small molecules to proteins and nucleotides have all 
been encapsulated.  A large body of in vivo studies has proven that particle size is a crucial 
factor in biodistribution, treatment of inflammation, and tumor bed penetration.  The effect of 
particle shape, on the other hand, has received much less attention and is not well understood.   
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Using advances at the interface between biology and the traditionally materials 
science-based field of soft lithography,11 researchers have only recently been able to access 
interesting shapes at the sub-micron size range on a sufficient volume scale to allow for 
extensive in vitro and in vivo biological studies.  In this technique, a biological pattern or the 
pattern on a hard substrate master, typically a silicon wafer, is embossed onto to a more 
flexible, crosslinked polymer material, the mold.  Soft lithography has been used extensively 
to mold naturally occurring objects and prepare patterns for microfluidics, and these topics 
have been the subject of recent reviews.12  A modification of these traditional lithographic 
methods, known as Particle Replication In Non-wetting Templates (PRINT®) (Figure 2.1),13-
21 has proven to be valuable for producing precisely-controlled polymeric vectors in the tens 
of nanometers to micron size range.  The PRINT process constitutes a tunable particle 
preparation platform by allowing entrapment (transiently, if desired) of diagnostic imaging 
agents and a wide variety of therapeutic cargo types while simultaneously providing 
tremendous latitude in the chemical composition of the carrier matrix.  In addition, the 
PRINT process is well suited for independent and precise variation shape, size, and modulus 
(stiffness) of the particle.  Indeed, PRINT affords unprecedented control and flexibility in the 
engineering of rationally designed particles, and thus it offers advantages as a fabrication 
method when compared to techniques employed to prepare traditional carriers such as 
liposomes, dendrimers, and colloidal particles.   
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Figure 2.1 Schematic representation of the PRINT process.  First an empty mold (green), a 
high surface energy polymer sheet (clear), and a roller (black) is brought into contact with the 
particle precursor solution and the mold (A); second, a roller evenly distributes particle 
precursor solution into the cavities of mold (B).  Third, excess particle precursor solution is 
wicked away by the high surface energy polymer sheet;  Fourth, individual particles are 
cured in the mold (C); Fifth, particles are removed from the mold using a sacrificial adhesive 
layer (D); And sixth, particles are collected or harvested using a number of different film 
based techniques and ultimately are dispersed in solution (E). 
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Until recently, the general conclusions drawn about particle size effects on various 
biological processes relied on studies using primarily spherical particles.  This is due to the 
fact that drug or contrast agent-loaded spherical particles with a narrow size distribution can 
be fabricated in a straight forward manner by a number of methods including emulsion, 
dispersion, and suspension polymerizations as well as precipitation and spraying techniques.  
The roles that particle size and composition play in biodistribution,22 cellular binding,23 cell 
entry pathways,24 cell uptake,25-27 and tumor bed penetration28, 29 have been studied 
extensively for macromolecular carriers and spherical particles. 
This work with spherical particles has resulted in valuable insights, but many 
naturally occurring objects are non-spherical, and biological processes typically occur under 
dynamic conditions in which the motion of spherical and non-spherical objects will differ.  
Indeed, Decuzzi and Ferrari’s theoretical work predicts that, under conditions of linear shear 
flow such as that in the bloodstream, oblate particles adhere more strongly to biological 
substrate than spherical particles; use of non-spherical particles for delivery is predicted to 
improve therapeutic and imaging efficacy.30  Experimentally, the combined effects of particle 
size, shape, charge, and chemical composition on biodistribution and cell entry have not yet 
been fully studied,28 but data suggest that seemingly small changes in chemical composition 
and modulus of the particle materials can have profound effects in vivo.  Clearly the major 
roadblock to examining the interdependence of particle size, shape, surface chemistry, and 
modulus is the previous lack of a suitable particle fabrication technique. 
Recently, techniques have been developed to prepare non-spherical particles by 
molding techniques such as the PRINT process, post-fabrication manipulation of spherical 
particles, or directly through microfluidics.  Although particle size impact on bioavailability 
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has been the subject of numerous studies, particle shape, on the other hand, has received less 
attention.  It is clear that particle shape is crucial to the mechanism of cellular entry17, 29, 31, 32 
and the release rate of the therapeutic cargo.33, 34 Shape effects on biological processes, 
however, are still not fully understood, particularly at the nanoscale, primarily due to past 
limitations in the control of particle fabrication.  Experimental explorations into the idea that 
unpredicted biological effects could result from non-spherical particle shapes are described in 
this section. 
A preliminary study of the biodistribution and pharmacokinetic study of 125I-labeled 
non-targeted, cylindrical particles prepared by the PRINT process in the 200 nm size range in 
healthy mice showed the expected uptake primarily in the liver and spleen.16, 18  The 
conventional strategies to reduce the rapid clearance from the bloodstream and uptake by the 
liver and spleen have been to increase hydrophilicity of the particle surface and reduce 
particle size.  In an alternative approach, however, Discher and coworkers have compared 
soft spherical assemblies to flexible filaments (worm-like particles) and found that the in vivo 
circulation time for the non-spherical filomicelles was about ten times longer than their 
analogous spherical counterparts.35  They extended their study to the delivery of paclitaxel 
and showed significant tumor shrinkage in a xenograft mouse tumor model, and showed that 
an increase in the filomicelle length had the same relative therapeutic effect as a similar 
increase in the paclitaxel dosage.  These results show that, in applications where a prolonged 
circulation time is desired, a long, worm-like structure can be more effective than a sphere. 
Besides the effect that particle shape can play on biodistribution parameters, particle 
size and shape also play a key role in the mechanism of passage through the cell membrane 
into the cell.  The biological details of cell internalization of macromolecules and particles 
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have been reviewed.36  Gratton et al. completed experiments showing size and shape effects 
on the uptake of highly crosslinked acrylic particles fabricated via the PRINT process by 
HeLa cells.17  In this work, a large library of crosslinked, poly(ethylene glycol) (PEG)-based 
particles of various sizes and shapes were prepared via the PRINT process with sizes ranging 
from 100 nm up to 5 µm and aspect ratios from 1 to 3.  Non-targeting particles fabricated 
from this formulation showed excellent uptake by HeLa cells, and cellular uptake 
mechanisms have been elucidated. Interestingly, this work showed that it is not the particles 
of lowest volume that enter cells at the fastest rate.  Instead, rod like particles similar in shape 
and size to many bacteria showed kinetically preferential uptake. 
The emerging understanding of the importance of particle shape in macrophage 
phagocytosis has been described and carefully studied by Champion.29, 37  Recognition of the 
fact that naturally occurring immunological targets vary widely in both size and shape 
provided motivation for this work.  By carefully varying shape at constant size, the authors 
concluded that it is indeed particle shape, rather than size, which plays a dominant role for 
determining the complexity of the local actin structure, and ultimately whether phagocytosis 
or simply spreading processes occur.  
Studies have also shed light on the roles played by size and shape of particulate 
carriers in the complicated biological processes of biodistribution, cell uptake, and 
bioavailability.  The ability to prepare particles in a manner than allows independent 
alteration of one variable at a time has proven fruitful for gaining insights into shape-
dependent biological processes such as phagocytosis.  Many techniques, such as stretching 
thermoplastic particles37 or S-FIL preparation of crosslinked particles as described above,38 
can be employed to prepare small amounts of shape-specific particles.  Practical, large-scale 
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manufacturing techniques for fabrication of non-spherical, shape-specific particles, however, 
is perhaps the biggest advantage gained by the application of the PRINT process to this area. 
2.3 Background on Nanoparticle Imaging Agents 
 
While size and shape clearly play an important role in nanoparticle drug delivery, the 
field of medical imaging has seen very few applications or systematic studies exploring the 
effect of variation in particle size and shape.  Therefore, the potential for important 
discoveries in the field of size and shape dependence on nanoparticle biodistribution and 
targeting is enormous.  Without a doubt, studies directed toward successful targeted delivery 
of size and shape-specific nanoparticles as novel therapeutic agents will be contingent on the 
successful visualization of their whereabouts in vivo.  Moreover, nanoparticle-mediated 
delivery of contrast agents provides an opportunity to reduce the toxicity effects associated 
with commonly employed contrast enhancement agents by improving specific biodistribution 
and reducing the required dosage.   
A number of different imaging modalities can be drawn upon for successful imaging 
of tissue through nanoparticle mediated delivery.  Such modalities include, but are not 
limited to, magnetic resonance (MR) imaging, positron emission tomography (PET), single 
photon emission computed tomography (SPECT), ultrasound imaging, and near infrared 
fluorescent (NIRf) imaging.  Here we focus on recent advances for imaging agent carriers in 
MR, PET, and NIRf imaging. 
2.3.1 MR Imaging 
 
Magnetic Resonance (MR) imaging plays an ever increasing role in the development 
of targeted nanoparticle therapeutics and imaging agents because of its high spatial resolution 
and unparalleled imaging of soft tissue.  Using conventional contrast agents such as iron 
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oxide nanoparticles and small molecule gadolinium (Gd) chelates, MR imaging is capable of 
providing excellent spatial resolution and 3D anatomical information. Because of its low 
sensitivity, however, relatively large concentrations of contrast agent are required to observe 
a modest increase in contrast.  The potential side effects caused by these relatively large 
contrast agent doses and decreased kidney function have spurred interest in particle-mediated 
delivery of MR contrast agents which can create contrast with lower doses and which 
generally avoid the kidney due to size constraints.  These contrast agents carry multiple MR 
beacons per particle and are capable of drastically improving the local contrast.  Nanoparticle 
contrast agents are paving the way for a new generation of imaging in which smaller doses 
will be required both to monitor the in vivo distribution of nanoparticles and to perform 
targeted imaging of diseased tissue and tumors.  Some of the most recent efforts to exploit 
polymer-based nanoparticles for delivery of iron oxide, Gd, and other paramagnetic moieties, 
are summarized below. 
In many respects, iron oxide nanocrystals are close to ideal nanoparticle contrast 
agents.  They are nontoxic and are easily surface functionalized with stealthing and targeting 
agents.39  Monodisperse samples of iron oxide nanocrystals have been shown to have 
different R1 and R2 relaxivities based solely on crystal size40 as well as on the surface 
coating.41  Spherical micelles of poly(styrene-b-acrylic acid) containing multiple iron oxide 
nanoparticles were recently reported by Taton and coworkers.42  The micelles were surface 
crosslinked into a covalently bound assemblies in the 40-140 nm size range using a diamine 
and functionalized further with a fluorescein derivative.  Using this method, larger polymer 
particles necessarily contained a larger number of iron oxide particles.  A different method 
recently reported by Sailor et al. describes improved relaxivity and improved targeting of 
	   46	  
tumor cells over traditional iron oxide nanoparticles using worm-like particles.10  The worms 
were composed of iron oxide nanoparticles trapped in strands of dextran.43  The authors 
believe that the unique shape of the elongated particles is the key to improving their efficacy.  
Figure 2.2 demonstrates two examples of different approaches to magnetic nanoparticle 
fabrication. 
 
Figure 2.2 TEM images of crosslinked block copolymer (PAA-co-PS) magneto-micelles 
containing 10 nm iron oxide crystals (A)42 and linear chains of dextran-coated magnetite 
(B)10. 
As stated earlier, iron oxide based imaging agents are popular because of their low 
level of toxicity and the ease with which one can modify their surface with a variety of 
ligands, stealthing polymer coatings and fluorescent beacons for multimodal imaging.  
Because the majority of iron oxide contrast agents create a decrease in signal intensity, 
causing tissue containing the contrast agent to “go dark,” researchers have pursued other 
compounds for contrast agents that increase signal intensity.     
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Small molecule chelates of Gd such as Gd-diethylenetriaminepentaacetic acid 
(DTPA) and Gd-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) and their 
derivatives create an increase in MR signal intensity.  Caravan has described how the limited 
sensitivity of MR requires millimolar concentrations of these agents before any contrast is 
observed.44  Coupling multiple Gd chelates to a single nanoparticle carrier can increase 
contrast enhancement per molecule.  A number of other synthetic approaches towards 
gadolinium-bound particles have been described including crosslinked micelles,45 peptide 
containing liposomes,46 dendrimers47 and hybrid systems.48  
Very few shape and size specific examples of nanoparticles were found that were 
capable of creating contrast for MR imaging.  One approach involved the encapsulation of 
MR contrast agent within spherical nanocapsules.  Landfester et al. demonstrate the use of 
inverse miniemulsions to encapsulate commercially available gadolinium-containing contrast 
agents inside spherical crosslinked dextran nanocapsules.49  The capsules are porous in 
nature allowing water exchange across the surface.  While the nanocapsules show a small 
reduction in relaxivity from that of the small molecule encapsulated within, the crosslinked 
dextran coating provides potential for surface functionalization and altered biodistribution.   
 Recently our group demonstrated the first example of Gd-containing shape and size 
specific particles for MR imaging.50  Two sets of biocompatible hydrogel particles 
encapsulating a commercially available Gd contrast agent  (OmniscanTM) were administered 
to healthy mice.  The two particle shapes were: 1.) cylindrical with a diameter of 200 nm and 
a height of 200 nm, 2.) cuboid particles measuring 2 µm on all sides.  Particle biodistribution 
was different depending on the size of the particles.  The small particles created an increase 
in contrast in the liver, kidney and blood vessels while the larger particles were observed 
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mostly in the liver and blood vessels.  Increased contrast was observed up to 3 hours after 
injection. 
2.3.2 Positron Emission Tomography 
 
  A number of groups have also adopted a nanoparticle platform for imaging using 
positron emission tomography (PET).  PET imaging uses positron emitting radioisotopes that 
can easily be bound to the surface, or interior, of a nanoparticle by simple metal chelation 
chemistry.  Positron emitters such as 64Cu are detectable at concentrations as low as 
picograms per milliliter.  The high sensitivity of PET makes it ideal for quantitative data 
analysis.  Additionally, the ability of positrons to easily penetrate tissue makes PET ideal for 
deep tissue imaging.  Some limitations of PET include low spatial resolution, the inability to 
provide significant anatomical information, and need for contrast agents that are not widely 
available. 
In 2007, Wooley et al. reported the optimization of radiolabeling crosslinked micellar 
assemblies poly(styrene)-b-poly(acrylic acid) with 64Cu-DOTA.51  In this work, a DOTA-
lysine derivative is covalently bound to the acrylic acid units of the copolymer that is 
subsequently labeled with 64Cu.  The copolymers were then used to form micelles and were 
surface-crosslinked using 2,2’-(ethylenedioxy)-bis(ethylamine).  By varying the relative 
amounts of DOTA-lysines per chain and the crosslinking ratio they were able to optimize 
signal enhancement as high as 400 µCi / µg.  Interestingly, the researchers found that the 
non-crosslinked micelles provided the most intense signal but pointed to the necessity of 
surface crosslinking for stable nanocontrast agents.  Wooley also showed that the particle 
size plays an important role in circulation times.   
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More recently, Scheinberg et al. showed the development of positron emitting 
hydrophilic carbon nanotubes.52-54  The nanotubes exhibited prolonged blood circulation 
times and improved tumor accumulation when compared to controls.  While carbon 
nanotubes have a number on interesting attributes for applications in targeted nanoparticle 
drug delivery, concerns exist about toxicity.55  Such concerns are leading many researchers to 
consider other carriers including biocompatible polymer matrices.  To the best of our 
knowledge, no examples of shape specific polymeric particles tagged with radioisotopes 
currently exist. 
2.3.3 Near Infrared Fluorescence Imaging 
 
 Interest in NIRf imaging research in small animals has exploded in recent years due 
largely to low costs, absence of ionizing radiation, and high sensitivity.  A gap in the near 
infrared spectrum found in most tissue makes it possible to image fluorescent tracers tagged 
to nanoparticles using sensitive NIR cameras.  Discher has exploited the use of these to 
examine the effect of particle shape on circulation times and tumor accumulation.9  Recently, 
his group showed that by increasing the particle shape from spherical to long worm-like 
filomicelles created a marked increase both in blood circulation times and in tumor 
accumulation. 
2.4 Multimodal Shape and Size Specific Contrast Agents Fabricated Using the PRINT 
Process 
 
 As mentioned above, a variety of imaging modalities are currently available for use as 
nanoparticle conjugated tracers for in vivo studies.  In addition, MR, PET, and NIRf have all 
been shown to effectively complement one another for use in small animal imaging studies.  
While each modality has its own strengths and weaknesses,56 it would be advantageous to 
have one particle that utilizes multiple imaging modalities.57  In this way, one could 
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capitalize on the strengths and circumvent the weakness of each modality.58  Conjugation of 
two or more types of imaging beacons to a shape and size specific nanoparticle would further 
compound the advantages of multimodal imaging with the ability of shape and size specific 
particles to plot specific biodistribution maps.  This would allow researchers not only to 
precisely follow the distribution of particles in vivo, but also to tailor the distribution 
properties themselves by changing the shape and size of the particles 
 In this work, biocompatible shape and size specific particles were fabricated using the 
PRINT process and used as multimodal contrast agents.  Particles were fabricated in four 
sizes and shapes.  First, a series of three particle shapes each with a critical diameter of 80 
nm was fabricated.  Particles in this series were either 90, 360, or 2000 nm in length.  In 
addition cylindrical particles 200 nm tall with a diameter of 200 nm were also fabricated.  
The particles were loaded with superparamagnetic iron oxide and a NIR fluorescent dye.  
After harvesting, particles were post functionalized with bifunctional ligand that was used to 
chelate 64Cu.  As such, the shape and size specific particles were traceable using three 
different imaging modalities, PET, MRI, and NIRf. 
2.4.1 Particle Composition 
 
 Particles were made up of five major components and were photochemically cured by 
radical polymerization in order to hold their shape in aqueous suspensions and to prevent the 
escape of paramagnetic cargo.  Particles were primarily composed of a poly(ethylene glycol) 
(PEG) diacrylate matrix.  This matrix was chosen because of excellent hydrophilic and 
biocompatible characteristics.  Next 20 wt % of aminopropyl methacrylamide (APMA) was 
added to impart primary amine functionality.  Aminoethyl methacrylate has been used 
historically in our lab for this purpose but has recently been shown to undergo numerous side 
	   51	  
reactions at elevated pH.59  These side reactions can eliminate the amine functionality 
making it impossible to surface functionalize particles through amine chemistry.  Iron oxide 
nanocrystals (10 wt %, 20 nm dextran coated, Chemicell, Gmbh) was added to impart 
paramagnetic behavior.  This causes a decrease in T1 (longitudinal) and T2 (transverse) 
relaxation times and causes a decrease in MR signal intensity (ie. negative contrast).  
DyLight 680 maleimide (1.5 wt %) was added to facilitate imaging by NIRf.  Finally, 1 wt % 
1-hdroxycyclohexylphenyl ketone was added as a soluble photo initiator.  See table 2.1 for 
details on particle composition.   






Dextran-coated iron oxide (20 nm) 10 
Dylight 680 maleimide 1.5 
1-Hydroxycyclohexyl phenyl ketone 1 
 
2.4.2 Particle Fabrication, Harvesting, and Purification 
 
 The pre-particle solution was diluted with dimethylformamide (DMF) to a 
concentration between 2.5-4.5 wt %.  This solution was drawn over a high surface energy 
sheet of poly(ethylene terephthalate) (PET) using a Mayer rod (2.54 µm, #2 RD Specialties 
Inc.) and dried briefly to remove excess DMF.  Patterned perfluoropolyether (PFPE) molds 
(Lot # MC1-0175-131) from Liquidia Inc. were used to fabricate particles (Figure 2.3).  
Using an in-house single nip lamination system, the thin film was laminated to, and peeled 
away from the patterned PFPE mold in one continuous motion.  Capillary forces of the mold 
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cavities cause the monomer solution to be preferentially trapped within the wells.  The low 
surface energy of the PFPE mold (8-10 dyn/cm)14 allowed excess monomer solution to be 
wicked away by the high surface energy PET (42 dyn/cm).  The filled PFPE mold was then 
relaminated to a sheet of PET and cured under UV light (365 nm, 12 J / cm2). 
 
 
Figure 2.3 AFM images of empty molds for each of the four particle sizes. 
 
 After curing, particles preferentially bound to the PET sheet and the PET sheet was 
delaminated from the mold (Figure 2.4).  Using a drop of filtered d.i. water, particles were 
gently removed from the PET sheet by agitation with a rubber scraper.  The particles were 
collected and centrifuged in order to remove large debris.  Small debris was then removed 
using a centrifugal filtration device (Utrafree-MC 100 nm cutoff, PVDF, Millipore Inc.). 
Because iron oxide formed aggregates in the pre-particle solution, the magnetic character 
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varies from particle to particle (see TEM image below).  As such, particles were then 
selected for high magnetic loading using a magnetic filtration device (MiniMACS, Miltenyi 
Biotec, Inc.).  The presences of primary amines on the surface of the particle played a large 
role in its stability as was shown by the change in zeta potential as a function of pH titration 
(See Figure 2.5). 
 
 
Figure 2.4 SEM images of particles of each particle size fixed to a PET harvesting layer.  
Insets show magnified particles from the same harvesting layer. 
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Figure 2.5 Titration of particle by addition of 25 mM NaOH.  Zeta potential is largely 
positive at physiological pHs. 
 
The particles were then drop cast from solution on a glass slide for imaging by SEM 
(Figure 2.6).  Particles were also imaged by TEM to show iron oxide loading (Figure 2.7).  In 
these images it is evident that the iron oxide is not evenly dispersed throughout the PRINT 
particle.  This is most likely a result of incomplete stabilization of the iron oxide in the pre-
particle solution.  While stability of the iron oxide nanocrystals can be improved by the 
addition of surfactants and other stabilizing agent, it was deemed unnecessary for these 
experiments.  A sample of the “naked” particles was saved for characterization purposes. 
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Figure 2.6 SEM images of free particles of each particle size drop cast from aqueous 
solution. 
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Figure 2.7 TEM images of all particle sizes containing iron oxide nanoparticles.  Scale bar is 
100 nm for each image. 
 
2.4.3 Particle Surface Functionalization 
 
2.4.3.1 Surface Functionalization with DOTA-bz-SCN 
 
 After purification and redispersed in metal free water, 10 mM DTPA (pH 8) was 
added to chelate any free metal from solution.  Particles were vortexed in DTPA overnight 
then centrifuged out of solution.  From this point on in the particle surface functionaliztion, 
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all aqueous solvents and buffers were purified using a Chelex® 100 resin to remove trace 
amounts of metal that could competitively bind to the DOTA ligand and prevent 64Cu 
binding.  In addition, all glassware was substituted with plastic containers.  Metal spatulas 
were substituted with poly(tetrafluoroethylene) (PTFE) coated spatulas.  And pipet tips were 
purchased from BioRad which was determined by the Scheinberg lab to have the lowest 
levels of residual metal contaminants.   
Residual DTPA was allowed to remain in the particle dispersion to prevent 
contamination by iron that might leach from the magnetite trapped within the particles.  Next, 
the pH was adjusted to 8.5 using a sodium bicarbonate buffer solution (0.5 M).  In a separate 
vial, a bifunctional macrocyclic ligand (DOTA-bz-SCN, Macrocyclics Inc.) was dissolved in 
metal free water (10 mg / mL).  The DOTA solution was then added to the particle dispersion 
(0.5 : 1.0, DOTA : -NH2), briefly sonicated, and then vortexed at room temperature for 1 
hour.  A sample of the DOTA-functionalized particles was saved for further characterization.  
A drop in zeta potential at all pHs is observed due to the presence of carboxylic acid groups 
in the place of primary amines (see Figure 2.8). 
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Figure 2.8 Zeta potential of DOTA-functionalized 200 x 200 nm cylindrical particles as a 
function of the pH. 
 
2.4.3.2 Surface Functionalization with PEG-NHS 
 
 Methoxy-poly(ethylene glycol) N-hydroxy succinate (mPEG-NHS) with a molecular 
weight of 5000 g / mol was then added to the dispersion at a ratio of 1 : 1 mPEG-NHS : -
NH2.  The PEG was allowed to react with the particles for 2 hours under constant vortexing.  
After the initial PEG conjugation, a second addition of 1 : 1 mPEG-NHS : -NH2 was added 
which was allowed to react for an additional 12 hours.  Samples of particles were taken after 
each addition of PEG for further characterization.  With each addition of PEG the zeta 
potential was brought closer to zero (see Table 2.2).  As the zeta potential approaches zero, 
the particle hydrodynamic radius increases.  This is a result of the loss of electrostatic 
stability as primary amines are converted to neutral PEG chains.  Finally, the particles were 
pelleted out of solution by centrifugation (14,000 rpm / 20,000 G) and resuspended in metal 
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free water.  This process was repeated two times to remove excess buffer and unreacted 
DOTA-bz-SCN and mPEG-NHS reagents.   
Table 2.2 Zeta potential of 200 x 200 nm cylindrical particles as a function of pH and 




1st PEGylation 2nd PEGylation 
pH 4 DLS = 309 DLS = 339 DLS = 533 
 Zeta = 39.8 Zeta = 31.1 Zeta = 17.5  
pH 6  DLS = 224 DLS = 351 
  Zeta = -18.7 Zeta = -5.64  
 
2.4.3.3 “Cold” Copper Chelation 
 
 Copper chloride in HCl was buffered to pH 4.5 with 3 M sodium acetate (NaOAc).  
Particles were then dispersed in 3 M NaOAc at pH 4.5.  An aliquot of copper solution was 
added to the particles in a screw-top eppendorf tube (used to prevent radioactive 
contamination with the gloves).  The particles were briefly sonicated and vortexed, then 
placed in a dry well incubator at 55-60 °C.  After 45 minutes, the particles were cooled to 
room temperature and a 10 µL aliquot of 10 mM DTPA was added to the dispersion to 
chelate any free copper.  The dispersion was mixed briefly and allowed to sit for an 
additional 10 minutes.  Finally, the particles were spun out of solution at 14,000 rpm.  If the 
particles were going to be used for characterization, they were redispersed in metal free 
water.   
Particles that were used for in vivo imaging were redispersed in a solution of 5 wt % 
dextrose in 0.9 % saline.  This solution was diluted to 1µg / mL with d.i. water and the zeta 
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potential and hydrodynamic radius of the particles was determined at pH 5 and 7 to be +27 
mV and -3.6 mV respectively.  The particles were shown to have an isoelectric point between 
these two pH ranges.  This is important to note because of the dramatic affect that particle 
zeta potential can have on biodistribution.  Particles with large positive zeta potentials are 
known to be rapidly taken up by the macrophages of the Reticulo Endothelial System 
(RES).60 
2.4.3.4 64Cu Chelation 
 
Chelation of 64Cu by surface functionalized PRINT particles was performed using the 
same chemical procedure as with “cold” copper.  Extra precautions, however, were taken to 
limit exposure to ionizing radiation created by 64Cu decay.  All wet chemistry was performed 
behind a 2” thick lead shield.  An upright plexiglass shield was used to eliminate the chance 
of splash back.  All of the standard personal protective equipment (PPE) was used including 
gloves, safety goggles, and a lab coat.  In addition, waterproof sleeves were worn along with 
a radioisotope counting badge and ring that was worn on my dominant hand. 
 In a typical experiment, 64CuCl2 from Washington University was diluted to 200 µL 
with 3 M HCl in order to make it easier to handle.  An aliquot of this solution was diluted 
with metal free 3 M NaOAc.  For a set of 3 animals, 3 mCi of 64Cu solution was added to 1 
mg of particles in 100 µL 3 M NaOAc and the pH was adjusted to between 4.5 and 5.  After 
sonicating and mixing, the particles were incubated at 55-60 °C.  After 45 minutes the 
particles were cooled to room temperature and 10 µL of 10 mM DTPA was added to chelate 
any free 64Cu.  After a 10 minute DTPA challenge the particles were pelleted out and 
redispersed in a solution of 5 wt % dextrose in 0.9 % saline to a concentration of 1 mg 
particles / mL.  Activity of the injected doses was typically 2-4 Ci / L although activity as 
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high as 8 Ci / L has been observed.  Higher activity is certainly achievable but was not 
desired because of the required dosage. 
2.5 Particle Characterization 
 
2.5.1 Particle Concentration and Iron Oxide Content Determination by 
Thermogravimetric Analysis 
 
 Purified particles were dispersed in metal free d.i. water.  A 25 µL aliquot of particles 
was deposited in a tared aluminum sample pan in the TGA.  Samples were brought to 150 °C 
at a rate of 10 °C / minute and held for 15 minutes in order to remove water from the 
dispersion and from the particles.  After 15 minutes, the sample temperature was raised to 
600 °C at a rate of 20 °C / minute and held at 600 ° C for 10 minutes to burn off any 
remaining organic.  The particle concentration was calculated as the remainder of the mass 
after the 150 °C isotherm divided by the initial mass (Equation 2.1).  Iron oxide 
concentration was determined as the mass remaining after the 600 °C isotherm divided by the 
mass after the 150 °C isotherm (Equation 2.2). 
   (Eqn 2.1) 
  (Eqn 2.2) 
2.5.2 Dynamic Light Scattering and Zeta Potential Analysis 
 
 Particle stability was examined using a Malvern ZetaPlus 90ZS Zetasizer instrument.  
Particles were typically dispersed in a low concentration electrolyte solution (1 mM NaCl or 
1/1000 PBS buffer).  See section 1.2.10.4 for further details on DLS/Zeta potential 
measurements. 
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 A colorimetric kit used to determine the primary amine content in a solution was 
purchase from Sigma.  The assay is ninhydrin based and a deep blue color occurs in the 
presence of primary amines.  The assay was calibrated using a glycine standard curve (Figure 
2.9).54  A 96 well plate was used in order to reduce error associated with the test.  Results for 
this assay should not be taken at face value.  Porous hydrogel particles most likely have a 
large amount of primary amines beneath the surface of the particle that may react with the 
ninhydrin to give a larger value than would be expected.  Additionally, particles in 
spectrophotometric studies are known to cause scattering that can potentially skew the 
results.  To circumvent this issue, the assay solution was filtered using a centrifugal filter to 
separate the particles prior to spectrophotometric analysis.   
 
 
Figure 2.9 Standard curve showing the linear relationship of absorbance at 405 nm vs 
primary amine concentration. 
 
 Amine concentration was determined for 200 x 200 nm cylindrical particles before 
and after PEGylation.  Prior to PEGylation, the Kaiser assay showed that there were, on 
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average, ~44,000 primary amines available.  On a weight percent basis, this corresponds to 
45 % of the total primary amines available per particle.  It is unlikely that this large of a 
percentage of the primary amines are actually available on the surface of the particle.  
Therefore, it is believed that the ninhydrin was able to penetrate into the particle and react 
with amines buried deep within. 
2.5.4 Determining DOTA Surface Concentration by Arsenazo III Transchelation Assay 
Analysis 
 
 DOTA concentrations were determined using another, different, colorimetric assay.61  
The Arsenazo III assay is a transchelation assay based on the loose complexation of Pb(II) 
with Arsenazo III (pink in color).  In the presence of DOTA, Pb(II) is quantitatively removed 
from Arsenazo III causing the arsenazo III to change colors.  When using this assay with 
particles that may nonspecifically bind to metal (ie. particles heavy in primary amines or 
carboxylic acid) it is a good idea to use blank particles (particles without DOTA) as a 
control.  See the standard curve in Figure 2.10. 
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Figure 2.10 Standard curve demonstrating the linear relationship of absorbance at 630 nm vs 
the concentration of DOTA. 
 
 Using the concentration of the particles, the estimated mass per particle (1.5 x 10 -9g / 
particle), and the determined DOTA concentration, it was possible to find the number of 
DOTA per particle.  The amount of DOTA per particle appeared to be somewhat dependent 
on the particle size.  For example the large particles (200 nm diameter, 200 nm height 
cylinders and 80 nm diameter, 2000 nm length wormlike particles) had ~25,000 DOTA per 
particle (0.130 DOTA / nm2).  The smaller 80 x 90 nm particles had only ~3,300 DOTA per 
particle (0.129 DOTA / nm2).  This was a relatively high number of DOTA which may have 
been a unique factor contributing to the highly pH sensitive zeta potential.  It was suspected 
that this pH dependence may have been the primary cause of high lung accumulation in in 
vivo studies.  
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2.5.5 Characterization of Near Infrared Particle Fluorescence 
 For NIRf imaging, particles were imaged using a Ivis Kinetic Optical Imaging system 
equipped with a EMCCD camera.  An excitation filter of 640 nm and an emission filter of 
740 nm were utilized.  The following parameters were used during NIRf imagin: f number, 
binning factor, field of view, and exposure times were 1, 4, 12.5, and 5 – 30 seconds 
respectively.  Data from animal and phantom study samples were acquired using Living 
Image® software.  The total efficiency from each region of interest (ROI) derived from the 
total counts per sample was used for comparison across animals, tissue samples, and 
phantom studies.   
 A phantom study of 200 nm diameter, 200 nm height cylinders chelated with “cold” 
copper was performed with a standard dilution curve of particles starting at 235 µg / mL 
down to 1.8 µg / mL.  Particles were prepared in 2 % agarose gel in 0.9 % saline solution.  
Particles exhibited detectible levels of fluorescence throughout this range of concentration 
(see Figure 2.11).  Therefore, in a mouse with an estimated 1.5 mL of blood, and an injected 
dose of 250 µg, concentrations as low as 1.1 % the injected dose (i.d.) would be detectable. 
 
Figure 2.11 A NIRf phantom study of particles in 2 wt % agarose gel was performed to 
determine an estimate of the limit of detection for particles in vivo.  Particle concentrations 
are 235 (A), 69 (B), 11 (C), 5.6 (D), 1.8 (E), 0 mg / mL (F). 
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2.5.6 Characterization of MRI Particle Contrast 
 
 For MRI imaging, particles were imaged using a 9.4 Tesla (T) Bruker Biospec 
instrument.  The instrument was equipped with a 25 mm QuadTransceiver mouse coil.  A 
small animal monitoring system was used to monitor temperature and breathing rate.  All 
scans were gated for animal breathing. 
 A phantom study of 200 nm diameter, 200 nm height cylinders was performed using 
the same sample that was used for the NIRf phantom study.  A RARE VTR T1 scanning 
sequence was used to quantify T1 relaxation times of the particles in agarose.  As 
demonstrated in figure 2.12, particles caused a marked decrease in intensity especially at 
high concentrations (69 - 235 mg / mL).  Lower concentrations however did not appear to 
significantly alter the T1 relaxation time.  As a result, for MRI to be useful for in vivo 
imaging with these particles, a targeted approach was most likely necessary to obtain high 
enough concentrations to create significant contrast. 
 
 
Figure 2.12 RARE VTR T1 Map of standard dilution phantom (left) and plot of T1 
relaxation time vs particle concentration (right). Particle concentrations are 235 (A), 69 (B), 
11 (C), 5.6 (D), 1.8 (E), 0 mg / mL (F). 
 
2.5.7 Characterization of PRINT Particles as PET Contrast Agents 
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 Cylindrical 200 nm diameter, 200 nm height cylinders were chelated to 64Cu at the 
Biomedical Research and Imaging Center (BRIC) at the University of North Carolina at 
Chapel Hill (UNC-CH).  Radio labeling efficiency was calculated as the amount of 
radioactivity bound to the particles divided by the total radioactivity in the chelation reaction 
(Equation 2.3).  To determine the radio labeling efficiency, a known amount of activity of 
64Cu was incubated with particles as described above.  Particles then were purified by 
centrifugal filtration.  The radioactivity remaining in the filter was bound to the particles.  
Typical radiolabeling efficiencies were between 85 – 90 %, a highly effective reaction yield 
when compared with work by other researchers.55   
   (Eqn 2.3) 
 Radiochemical purity, defined as the radioactivity in a particle dispersion that is 
bound to the particle, was also determined.  To find the free 64Cu and 64Cu-DTPA, an instant 
thin layer chromatography technique (I-TLC) was performed according to the literature.52  
Two strips of silica-impregnated paper (Whattman, Inc.) were spotted with a particle 
dispersion that was ready for injection.  The strips were developed according to a procedure 
developed by Scheinberg.62  The first strip was developed in 10 mM ethylenediamine 
tetraaceticacid (EDTA) while the second strip was developed in 10 mM NaOH in 0.9% 
saline solution.  Free 64Cu travels at the solvent front in EDTA and is found at Rf = 1.0.  Free 
64Cu-DTPA travels at the solvent front of NaOH and is stabilized by the sodium chloride in 
this solution and, therefore, it ends up at Rf = 1.0.  Particles did not travel with either solvent 
front and had the value Rf = 0.0.  Strips were cut in half at Rf = 0.5.  Radiochemical purity 
was determined using equation 2.4.  Typical radiochemical purities were 95-99%.  Higher 
! 
Radiolabelingefficiency = AparticlesAtotal
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purities were possible by repeating the purification steps, however, particle loss was 
substantial with each additional step and 99% purity was therefore deemed sufficient. 
  (Eqn 2.4) 
 The specific activity of the particles was calculated by dividing the activity of 
particles in solution by the mass of the particles in solution (see Equation 2.5).  According to 
this equation particle activity was typically > 5 Ci / g.  Specific activities of 15 Ci / g have 
been reported for nanoparticle-based imaging using PET.52  Other groups have also reported 
much higher specific activities (>100 Ci / g) for PET imaging but these groups typically 
inject much lower quantities of particles (ie. 0.25 mg particles / kg animal).63  With specific 
activities of 5 Ci / g, it was possible to inject animals with particle concentrations similar to 
what have been performed in the past in our group (3.3 mg / mL)16 and still get high enough 
activity for PET imaging over 24 hrs (typically need 500 – 800 µCi). 
  (Eqn 2.5) 
2.6 In Vivo Imaging Study 
 
All animal studies were conducted in accordance with the Animal Wellfare Act and 
the Guide for Care and Use of Laboratory animals.  The animal protocol was approved by the 
Institutional Animal Care and Use Committee (IACUC) for the UNC-CH.  Healthy female 
BALB/c mice (6-8 weeks old, ~20 g) were injected using a tail vein catheter set up (Figure 
2.13) which made it possible to get an image prior to and immediately post injection.  
Animals were anesthetized with 1.8-2% isofluorane.  Breathing rate was either monitored 
using a small animal monitoring system or by constant visual inspection.  Animal 




SpecificActivity = ParticleActivity[Ci]ParticleMass[g ]
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animal core temperature, as measured by rectal thermometer, was used to keep the animal at 
a comfortable resting temperature.  A 250 µL bolus injection of 1 mg / mL (~12.5 mg particle 
/ kg mouse) was used in all experiments.  Just prior to injection, particles were thoroughly 
sonicated (pulsed 1 second on one second off for 3 minutes) using a cup horn sonicator at 
100 % power.  This was done to reduce the occurrence of particle aggregation.  After 
imaging animals were sacrificed and organs were harvested for further characterization.  All 
PET scans were performed on n = 3 animals in order to demonstrate quantitative analysis of 
particle biodistribution and pharmacokinetics.  Imaging performed using MRI and NIRf 
modalities was performed on one animal for each particle size in order to demonstrate proof 
of concept for imaging in multiple modalities with one particle.   
 
Figure 2.13 Cartoon of tail vein catheter setup. 
2.6.1 In Vivo PET/CT Results 
 
 Animals were fitted with a tail vein catheter with a hold up volume of 50 – 100 µL 
and placed in a GE Explore Vista PET / Computed Tomography (CT) small animal imaging 
system.  Animals were imaged by CT prior to injection.  PET scanning was started as soon as 
particle injection began (bolus injections lasted 30 seconds).  The images from CT and PET 
scans were overlayed using Amide software.  Regions of interest were selected by hand.  
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Typically, the outline of an organ was selected in the PET or CT view.  At least 5 focal 
planes were averaged together and used for each organ in an effort to reduce error. 
A heparin / saline flush was used through the tail vein catheter to ensure that the 
entire dose had been administered to each animal.  A dynamic scan lasting one hour was 
taken to monitor particle biodistribution over this time.  Next, animals were scanned at 6 
hours, and again at 24 hrs.  Animals were then sacrificed and their organs were harvested for 
examination using a gamma counter. 
 Particles were observed to travel through a major blood vessel to the heart where they 
were distributed to the lungs.  Particles accumulated quickly in the lungs.  They then were 
distributed much more slowly to the other organs.  The majority of particles ended up in the 
liver, spleen, and lungs.  Figure 2.14 demonstrates this effect in which one animal was 
injected with 200 nm diameter, 200 nm height cylinders and was imaged continuously for 1 
hour, then again at 6 hours, and finally at 24 hrs.  A large increase in intensity is observed 
first in the lungs.  After about 30 minutes a significant accumulation of particles is observed 
in the spleen.  Accumulation of particles in the liver can also be distinguished from 30 
minutes on. 
	   71	  
 
 
Figure 2.14 A representative dynamic PET scan (t = 0 – 60 min) and two static scans (6 and 
24 hrs) of a mouse injected with 200 nm diameter, 200 nm height cylinders. 
 
In addition to visual observation of the intensities of organs over time, it was possible 
to compare the relative intensities of the ROIs graphically.  Figure 2.15 demonstrates the 
standard uptake value, or SUV, (Equation 2.6) of particles over time in the lung, liver, 
spleen, and heart.  Here, it is readily apparent that there is a large accumulation of particles in 
the lung. 
€ 
SUV = RadioactivityConcentrationInROIInjectedDose /AnimalWeight   (Eqn. 2.6) 
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Figure 2.15 Averaged SUV data (n = 3 mice) for particle accumulation in the liver, spleen, 
lung and heart. 
 
All PRINT particles exhibited short, irregular blood circulation half-lives (t1/2).  When 
compared to the literature (2.5 µm length filomicelles t1/2 = 5.2 days)35, these PRINT 
particles had relatively poor performance as shown by their short circulation times 
demonstrated in Table 2.3.  The short half-life is probably the result of rapid uptake by the 
RES and entrapment of particles in capillary beds.  This is supported largely by the high 
signal intensities found in the liver, spleen, and lungs.  It is believed that this is largely due to 
the large number of DOTA ligands on the surface of the particle.  Improved electrostatic and 
steric stability through optimized surface PEGylation will be required for improved 
circulation half-lives.  Flexibility of the higher aspect ratio particles may also be an important 
factor in improving particle circulation times. 
Table 2.3 Particle half-life in blood circulation. 
 
 Control 80 x 90 nm 80 x 360 nm 80 x 2000 nm 200 x 200nm 
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Time (min) 12.90 31.9 21.4 15.1 32.2 
Stdev (min) 0.4 26.4 16.1 4.4 19.8 
 
Over the first hour p.i., particle accumulation in the lungs was high for all four 
particle sizes.  The total exposure, or area under the curve (AUC), of the lungs to particles 
was compared to the AUC of the liver and spleen (see Table 2.4).  Lung exposure at 45 
minutes was much higher than in the spleen or liver.  After 24 hours exposure to particles, 
the liver and lungs experienced similar levels of exposure to the particles with the exception 
of the 80 x 360 nm particles.  It is not fully understood why exposure of these particles to the 
lung is so much higher than to the liver and spleen.  But our suspicion is that when the 
particles are injected (injection is pH 5, zeta potential is +15 mV) they are highly positive 
and may be targeted by the RES.  Additionally, the level of DOTA per particle was 
maximized for these early studies in order to ensure positive results with 64Cu chelation.  As 
a result, PEG densities on the particle surface were not as high as one would like.  Low PEG 
densities have been shown to lead to higher levels of particle aggregation and rapid 
elimination by the RES.64 
Table 2.4 Ratio of the AUC of the lungs to the liver and lungs to the spleen at 45 minute and 
24 hour exposure times p.i. as a function of particle size. 
 
 Exp. Time Control 80 x 90 nm 80 x 360 nm 80 x 2000 nm 200 x 200 nm 
Lungs: 45 min 1.5±1.2 11±4 13±5 4±2 6±4 
Liver 24 hr 4.4±0.7 1.5±7 8±4 0.8±0.1 1.4±0.4 
Lungs: 45 min  10±5 17±1 5.1±0.1 6±4 
Spleen 24 hr  1.1±0.3 8±2 0.8±0.2 1±0.5 
 
Rapid accumulation in the lung was most likely a result of the positive zeta potential 
(+27 mV) of the particles prior to injection.  Particle concentration in the lungs decreased 
slowly over the first hour for all of the particle shapes with the exception of the worm-like 
particles (80 x 2000 nm).  It is believed that the length of the particles may have made it 
difficult for the particles to become lodged in the small capillary beds of the lungs.  Further 
analysis by confocal imaging and TEM will be necessary to elucidate the mechanism that 
differentiates the worm-like particles from the rest of the shapes in the lung. 
2.6.2 In Vivo Near Infrared Fluorescence Results 
 
 In order to demonstrate the ability of the particles to act as a contrast agent for in vivo 
NIRf, one animal per particle size was imaged using Ivis Kinetic NIRf instrument.  Animals 
were imaged at 1.5 hrs, 24 hrs, and after the animals were sacrificed at 24 hrs, their organs 
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were harvest and imaged.  Organs from all of the four animals that were injected with 
particles and one control animal were compared side by side to show relative amounts of 
particle accumulation at 24 hrs. 
 NIRf images of animals 1.5 hrs p.i. corresponded well with the results obtained by 
PET imaging.  High levels of signal intensity were observed in the lungs for all particles as 
well as just below the lungs in the liver and spleen region.  At 24 hrs, signal intensity in the 
lungs had decreased somewhat while intensity in the liver and spleen increased (see Figure 
2.16).  Imaging of live animals with NIRf is useful for superficial tumors and for qualitative 
analysis of particle distribution.  Limited depth of penetration, scattering, and other artifacts 
associated with NIRf make this method inadequate for quantitative analysis of particle 
biodistribution.  To get a better picture of particle biodistribution by NIRf, it was necessary 
to sacrifice the animal and harvest the organs. 
	   75	  
 
 
Figure 2.16 NIRf images of a control mouse with no injected particles (A), a mouse injected 
with 200 x 200 nm cylindrical particles at 1.5 hrs (B), and the same mouse at 24 hrs (C). 
 
 Similar to the PET studies, organs associated with the RES had the highest signal 
intensities.  In general, the lungs showed the highest particle accumulation, followed by the 
liver, and then the spleen.  Particle accumulation in different organs is demonstrated in 
Figure 2.17 and graphically in Figure 2.18.  It is difficult to draw conclusions from these 
results as only one animal was used per particle size. The use of one animal was deemed 
sufficient for the purpose here of demonstrating contrast in vivo with shape and size specific 
particles.  As a result, one should pay attention to the relative intensities of organs from one 
animal (ie. lung, liver, and spleen from mouse 1) but not compare the intensity of the same 
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organs between different animals (livers from mouse 1, 2, and 3).  Obviously, for a more 
detailed study of particle biodistribution, 3 or more animals should be used. 
 
 
Figure 2.17 NIRf images of lungs (A), liver (B), spleen (C), and kidney (D) of mice injected 
with 200 x 200 nm (i), 80 x 2000 nm (ii), 80 x 360 nm (iii), and 80 x 90 nm (iv) PRINT 
particles.  A fifth mouse (v) was not injected with particles and was used as a control. 
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Figure 2.18 Particle accumulation determined by NIRf as a function of particle size at 24 hrs 
p.i. 
 
2.6.3 In Vivo MRI Results 
 
 After inserting a tail vein catheter with a hold up volume of 50 – 100 µL, animals 
were stabilized in the MRI (BR = 60 – 70 bpm, Temperature = 30 – 33 °C).  Animals were 
scanned prior to injection using a variety of different scanning parameters including coronal 
TurboRARE-T2 2D and FLASH multislice as well as axial MSME T2 maps.  One animal 
was injected for each of the 4 particle sizes.  Animals exhibited minor decreases in intensity 
in the liver 1 hour post injection (Figure 2.17).  Within error, no quantifiable change in 
relaxation time was observed but the gray parenchyma of the liver did appear slightly darker.  
It is obvious that in order for these particles to be useful as contrast agents for MRI, higher 
local concentrations would be necessary.  This is possible by either increasing the injected 
dose, or by the addition of targeting ligands to the surface of the particle. 
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Figure 2.19 In vivo MRI scans of a mouse injected with 200 x 200 nm cylindrical particles 
containing iron oxide nanocrystals.  Coronal scans of the mouse take prior to injection (A) 
and 1 hr p.i. (B) show the vessels delineating the liver parenchyma (grey) just below the dark 
mass of the lungs.  Axial T2 mapping scans prior to (C) and 1 hr p.i. (D) show a minor 




A number of studies were reviewed in which polymer-based nanoparticles have been 
used as carriers for therapeutics and imaging contrast agents.  Recent studies have indicated 
that anisotropic, worm-like particles can enhance circulation time in comparison to previous 
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studies with spherical particles.  Studies such as these lead us to believe that the ability to 
systematically modify the size and shape of particles may allow us to rationally alter the 
biodistribution of nanotherapeutics.  The PRINT method has allowed us the ability to 
fabricate multimodal contrast agents of any shape and size allowing us to track the 
distribution of the particles using a variety of methods.  With this new capability, completely 
monodisperse samples of a variety of particle shapes have been prepared allowing the 
quantitative and qualitative analysis of particle biodistribution using PET, MRI, and NIRf.   
2.8 Future Directions 
A number of important questions remain to be answered in the field of 
nanotherapeutics.  Among these questions, some of the most crucial are also the most basic.  
Can size and shape play an important role in particle circulations times?  Will size and shape 
be important in tumor uptake and retention?  Do extreme particle aspect ratios (10:1 and 
higher) help prevent phagocytosis and allow for prolonged circulation in the blood?  The 
ability to quantify particle biodistribution using radio labeled particles demonstrated in this 
work will make it possible to rapidly and quantitatively address many of these questions. 
Before this happens however, a number of small but significant particle optimization 
studies should be performed.  First off, it is imperative that a strong understanding of particle 
surface chemistry is obtained.  Opsonization and binding of larger proteins has been shown 
to have deleterious effects on particle elimination from the blood stream by the RES.65  High 
density brush conformations of PEG on the surface of nanoparticles has been shown to 
reduce the rate of clearance from the blood.  Optimization of high density PEG on the surface 
of PRINT particles will be crucial going forward.  A number of rapid studies can be 
performed using a high throughput flow cytometry-based method capable of running up to 96 
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experiments in less than 30 minutes.  Additionally, using PRINT, it is possible to screen 
surface functionalization chemistries using particles bound to a harvesting layer.  In this 
manner, one can envision running multiple iterations of a reaction on a small batch of 
particles and rapidly zero in on optimal conditions for PEGylation. 
Before PEG studies are performed, it will be necessary to pare down the surface 
density of DOTA.  In this work it was shown that large portion of the particle surface was 
coated with DOTA.  While this high level of DOTA made Cu64 conjugation straightforward, 
it also led to instability and aggregation issues that could be solved if more particle surface 
area was available for PEG which has been shown to work well as a steric stabilizer.  It 
should be possible to reduce the density of DOTA on the surface of the particle by at least 
1000 fold and still get acceptable radio labeling levels for PET imaging.  This would lead to a 
large increase of available surface area for PEG functionalization.  The resulting particles 
would still be visible using PET/CT imaging but would be less prone to aggregation. 
Another crucial parameter that has yet to be examined is the effect that particle 
modulus has on circulation times in the blood.  It is understood that red blood cells (7 µm 
diameter) are capable of circulating for prolonged periods of time.  In order to navigate 
capillary beds that contain passages only 3 µm in diameter, these cells must be able to flex 
and contort themselves up to 100 % of their own length.  Indeed, it is believed that part of the 
criteria for red blood cell removal is based on rigidification of the cells over time.66  Once the 
cells are no longer able to bend and stretch, they become trapped in the sinusoids of the 
spleen and are eliminated from the blood stream.  On a smaller scale nanoparticles may have 
similar interactions with the sinusoids of the liver and spleen.  With the ability to manipulate 
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particle modulus without changing particle size and shape using the PRINT process, we are 
at a distinct advantage to try to answer this question.   
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 Section 3: Microscale Particle Fabrication and Analysis 
 
Chapter 1:  
 
3.1 Alignment and Crystallization of Electrically Polarizable Anisotropic Particles 
Fabricated Using the PRINT Process 
 
3.1.1 Introduction to the Alignment and Crystallization of Electrically Polarizable 
Anisotropic Particles 
 
The assembly of colloidal particles is a rich and growing area of materials science, 
with great potential for a broad range of applications including electronics, optics and 
biotechnology.  Within this field, the bulk of research has been devoted to studying the 
assembly of isotropic spherical particles.  In spite of this, there has been a growing interest in 
studying the assembly of anisotropic particles due to the more complex and useful structures 
that these particles can potentially assemble into.1, 2  These novel structures are in great 
demand in the field of photonics where unique crystal symmetries, beyond hexagonally 
close-packed spheres, are desired.  They can also impact the fields of optoelectronics, 
memory storage,2, 3 and sensors, as well as providing the platform for new discoveries and 
phenomena.  The fabrication of inorganic anisotropic particles is a heavily-researched field, 
and a wide range of nanoparticle shapes have been generated using established synthetic 
routes, including prisms, rods, highly branched particles, and tubes.  As a result, the assembly 
of inorganic anisotropic particles has been studied to some degree.4-6  There are far fewer 
reports on the assembly of anisotropic organic particles.  This may, in part, be due to a lack 
of effective fabrication processes for the preparation of these particles with the 
monodispersity, control and range of compositions required for in-depth study. Of the 
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published studies, the shapes appear to be limited mainly to rod-like and disc-like particles.7-
10  There are only a couple of examples of assembling anisotropic organic particles with more 
exotic shapes.  Hernandez and Mason11 used depletion interactions to observe assemblies of 
their LithoParticles with cross and donut shapes (1-3 µm in size). They observed columnar 
assemblies (Figure 3.1 A b & c), as well as lock-and-key aggregation (Figure 3.1 A d & e) of 
the crosses with the donuts (Figure 3.1 A).  Doyle et al.12 also investigated the assembly of 
relatively large (approximately 30-50 µm in size) amphiphilic wedge-shaped polymeric 
particles, which assembled into micelles (Figure 3.1 B). 
 
Figure 3.1 Lithoparticles formed by automated stepper lithography (A)11 were assembled via 
depletion interactions created by nanoemulsion droplets (not shown).  Amphiphilic particles 
formed using Continuous Flow Lithography (CFL) system were assembled into micelles 
using a oil (o) in water (w) emulsion technique (B).12 
 
3.1.1.1 Particle Fabrication Background 
 
Both top-down and bottom-up approaches have been used to prepare anisotropic 
organic particles with varying degrees of success.  Bottom-up approaches13-16 have been used 
to synthesize anisotropic organic particles in a variety of shapes including discs, ellipsoids, 
“snowman-like”, and “confetti-like” particles.  These processes are, however, sometimes 
complex and are generally limited in terms of shape, composition and dispersity.  Top-down 
approaches, such as templating,8, 9 microfluidics12, 17-22 and different lithography approaches7, 
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11, 23-25 have the advantage of improved control over feature shape and size, and the 
possibility for more monodisperse particle synthesis, however these processes sometimes 
suffer from incompatibility with different reagents, limitations on the particle size and 
scalability.  Previously, the nanomolding technique, Particle Replication in Non-wetting 
Templates (PRINT),26-31 was reported to fabricate monodisperse, nanometer- and micron-
sized particles of varying size, shape and composition, such as conical triacrylate 
nanoparticles and poly(ethylene glycol) arrows.  This technique stands out because of the 
high degree of molding resolution, the broad range of chemistries that can be molded, and the 
ease with which reel-to-reel technology can be incorporated for scalability.  Thus, it is ideally 
suited to the synthesis of unique, highly anisotropic particles in a wide range of 
compositions, and with particular utility in the rapidly growing nanomedicine field.  PRINT 
can also be used in a straightforward manner to investigate the colloidal assemblies generated 
by such particles.  The use of dielectrophoresis to study the assembly of highly anisotropic 
polymer particles fabricated with the PRINT process is reported in Section 3.1. 
3.1.1.2 Dielectrophoresis 
 
Dielectrophoresis, the interaction of liquids or particles with nonuniform AC electric 
fields, has been shown to be a facile method for the assembly of colloidal suspensions.32-37  
The movement of particles is dependent on the local electric field, the dielectric properties of 
the particles and the suspending medium, frequency, surface charge density, concentration of 
free charges in the vicinity of the particle, geometry of the particle, and electrode 
geometry.32, 38, 39  Typically, particles exhibit chaining phenomena in nonuniform AC electric 
fields.  This process has been used to align particulates, such as carbon nanotubes, ceramic 
nanoparticles and glass fiber, in composites for improved mechanical or electrical 
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performance.40-43  In these composite examples, the particles were generally highly 
polydisperse and comprised of random nonspecific shapes, so the assemblies were not well-
structured.  Most of the examples of the dielectrophoretic assembly of monodisperse 
colloidal systems have been with spherical particles, which generally crystallize into 
hexagonal close packed assemblies.2  Some research has focused on the assembly of 
anisotropic rod-like particles via dielectrophoresis.  This work has primarily focused on 
biological particles,39, 44-47 such as cells, viral particles, and bacteria for the fabrication of 
biofilms and tissue or in diagnostics and separation.  Both experimental and theoretical 
studies have indicated that ellipsoidal particles exhibit more complex behavior in nonuniform 
electric fields, because there are more degrees of freedom from the typical isotropic case of 
the sphere.48  In fact, there is a preferred or more stable orientation for these shapes, where 
they align with their long axis parallel to the axis of the electric field.47-49  Here, the effect of 
particle shape on the behavior of anisotropic polymer particles in nonuniform AC electric 
fields is explored.  
3.1.2 Experimental 
 
3.1.2.1 Particle Composition 
 
The following reagents were purchased through Sigma Aldrich and used as received: 
2,2-diethoxyacetophenone (DEAP) (95%, Aldrich), 2-aminoethyl methacrylate 
hydrochloride (AEM) (90% Aldrich), fluorescein o-acrylate (97% Aldrich), dimethyl 
sulfoxide (DMSO) (≥99.9% Aldrich), hexadecyltrimethylammonium bromide (CTAB) 
(Aldrich).  Trimethylolpropane ethoxylate (14/3 EO/OH) triacrylate (MW 912 g/mol 
Aldrich) was de-inhibited using adsorption alumina (Fisher).  1-vinyl-2-pyrrolidinone (VP) 
(Aldrich) was distilled prior to use.  2-propanol (histological, Fisher) and acetone 
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(histological, Fisher) were both filtered with a 0.2 µm nylon filter (Millipore) prior to use.  
Cyanoacrylate adhesive (Zap CA PT-08, Pacer Technologies) was used as received.  The 
perfluoropolyether (PFPE) prepolymer resin (FluorocurTM, Liquidia Technologies, Inc.) was 
thoroughly mixed with 0.1% (w/v) DEAP photoinitiator before use.  Double-sided adhesive 
slide separators (SS1X9, Grace BioLabs) were used with standard 1x3” glass slides (Fisher 
Scientific) for preparation of the dielectrophoresis (DEP) cell. The untreated side of 
poly(ethylene terephthalate) (PET) sheets (Melinex 453, DuPont) was used for mold support 
and for monomer distribution and removal. 
3.1.2.2 Master Fabrication 
 
Silicon wafers were patterned for use as master templates using methods described in 
Section 1. 
3.1.2.3 Mold Fabrication   
 
Initially, a silicon wafer, patterned with one of the four shapes (boomerang, disc, 
hexnut, or rod) was placed in a leveled UV-curing chamber.  A 5-10 mL aliquot of PFPE 
prepolymer was deposited on the surface of the wafer and allowed to spread until it reached 
the edges.  The chamber was then purged under low flow nitrogen to remove oxygen from 
the chamber without disturbing the exposed surface of PFPE.  After which, the uncured mold 
was exposed to UV light (λmax = 365 nm, P ≥ 20 mW/cm2) for an additional 3 minutes.  
Molds were gently peeled off the master then placed feature side up on a clean sheet of PET 
for ease of handling. 
3.1.2.4 Monomer Solution 
 
The first design parameter of the particles was to create a cross-linked architecture 
that was highly miscible with the other functional monomers and had minimal swelling in 
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aqueous environments. Trimethylolpropane ethoxylate triacrylate was ideal for this role 
because of the amphiphilic nature of the ethylene oxide repeat unit and its high functionality.  
Next, a small amount of fluorescent monomer, fluorescein o-acrylate, was incorporated into 
the hydrogel matrix to facilitate optical analysis. AEM was then added to the monomer 
mixture to impart amine functionality that will be used for particle functionalization in future 
projects.  Finally, the DEAP photoinitiator was used because it was easy to handle (liquid at 
room temperature), highly miscible with the three monomers, and, in comparison to thermal 
initiators, facilitated rapid and convenient polymerization conditions that were compatible 
with the PRINT process.  Monomer solution was prepared as follows: First, 20 mg 
fluorescein o-acrylate and 30 mg AEM were dissolved in 100 µL DMSO.  Next, 940 mg de-
inhibited trimethylolpropane ethoxylate (14/3 EO/OH) triacrylate was added to the solution 
and mixed thoroughly by vortexing for 2-3 minutes until the solution was optically 
transparent.  Finally, 10 mg DEAP was added and the solution was again vortexed until 
optically transparent. 
3.1.2.5 Particle Fabrication 
 
A small aliquot (20-30 µL) of the monomer solution was deposited on the surface of 
the PFPE mold where it met with the PET sheet.  Using an in-house single-roll laminator, the 
monomer was evenly distributed over the surface of the mold.  Excess monomer solution, 
visible as small beads on the PFPE surface, were wicked away using a clean sheet of PET on 
another heated (80 °C) laminator.  The filled mold was then placed back in the UV-curing 
chamber where it was again purged for three minutes with dry nitrogen and subsequently 
exposed to UV-light for an additional 3 minutes under continued purge.  See Figure 3.2 for a 




Figure 3.2. Schematic representation of the PRINT process.  A) Empty mold (green), high 
surface energy polymer sheet (clear), roller (black); roller is brought into contact with the 
pre-particle solution and the mold; B) Roller evenly distributes pre-particle solution into 
cavities of mold.  Excess pre-particle solution is wicked away by the high surface energy 
polymer sheet; C) Particles are cured in the mold; D) Particles are removed from the mold; 
E) Particles are collected in solution. 
 
3.1.2.6 Particle Harvesting 
 
The filled mold was hand laminated over small aliquot (100 µL) of 
poly(cyanoacrylate) on a glass slide and allowed to set for 20-30 minutes.  The mold was 
then peeled back from the glass slide leaving an array of particles firmly bound to slide by 
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the poly(cyanoacrylate).  The particles were then rinsed with filtered acetone to remove them 
from the glass slides and collected in 50 mL falcon tubes for further purification. 
3.1.2.7 Particle Purification 
 
After harvesting, particles were purified to remove residual cyanoacrylate and other 
unwanted debris through a process of repeated rinsing with acetone.  Initially, particles were 
pelleted out of solution by centrifugation (5 minutes, 137 G).  The supernatant was then 
decanted and the particles were resuspended by vortexing gently for 1 minute.  This process 
was repeated at least 5 times.  Particles were then gravimetrically filtered to remove any 
debris.  Finally a 100 µL aliquot of the particle slurry in acetone was placed in a preweighed 
eppendorf tube and was dried in vacuo to determine the concentration of particles. 
3.1.2.8 Sample Preparation 
 
In order to avoid particle aggregation, particles were never completely dried.  Instead, 
particle samples were prepared by combining 1.0% (w/v) aqueous CTAB solutions with 
particle/acetone slurries.  The solutions were then placed under vacuum to remove the excess 
acetone.  Final particle concentrations were as follows: hexnuts were 5 mg/mL, rods were 10 
mg/mL, discs were 20 mg/mL, and the boomerangs were 10 mg/mL.  For DEP experiments, 
aliquots of 11 mL were placed in the sample cell.  Sample pH was between 5.5-6.5.  No 
buffer was added. 
3.1.3 Experimental Setup 
 
3.1.3.1 Electrical Cell Setup 
 
The electrodes were fabricated following various procedures described elsewhere. 36, 
50, 51  Briefly, glass slides fit with a 1-2 mm wide adhesive mask were coated with 70-90 nm 
Pd/Au allow using a sputter coater (Model 108 Auto Sputter Coater, Cressington Scientific 
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Instruments) to form two planar electrodes.  An adhesive gasket was placed over the 
electrodes.  A 10-11 µL aliquot of colloidal particle solution was placed on the surface of the 
slide and was sealed in place using a cover slip (1.5 Gold Seal).  The alternating electric field 
was produced by a wave function generator (Model 180 Function Generator, Wavetek) and 
then amplified (6824A DC Power Supply Amplifier, Hewlett Packard).  Field intensities 
ranged from 10-50 V with square wave frequencies between 500-5000 Hz.  Experiments 
were typically run at 40 – 50 V and 500 Hz (see Figure 3.3). 
 
 
Figure 3.3 Dielectrophoretic cell schematic.  Particles, shown in red are placed in a cell with 
two electrodes.  An alternating potential is applied across the cell creating a dipole moment 




Individual particles were imaged using a Hitachi S-4700 scanning electron 
microscope.  The samples were dried from acetone slurry at room temperature in air and then 
coated with Pd/Au (3-5 nm) in the sputter coater. Particle alignment, packing, and 
crystallization were observed using a Zeiss Axioskop 2 MAT incident light microscope fitted 
with an AxioCam MRm digital camera.  Movies of particle alignment were captured using 
 95	  
Axiovision software.  Movie frames were captured roughly every second for a minute 
(hexnuts, discs, and boomerangs) and five minutes (rods). 
3.1.3.3 Turbidity Experiments 
 
Particle samples (5-20 mg/mL) were prepared in 0.2, 1.0, and 5.0% (w/v) aqueous 
CTAB solution.  A cuvette (100 µL, QS), with a path length of 1 cm, containing the particle 
sample was then vortexed and placed in a plate reader (Spectra Max M5, Molecular 
Devices).  A kinetic experiment was performed at λ = 490 nm, reading absorbance every 30 s 
for 1 hour at 22 oC. All experiments were repeated three times to establish reproducibility.  
The turbidity, τ, defined as the attenuation of the light beam by scattering when passing 
through a sample, was determined from equation 3.1 below, where Io is the incident intensity 
of light, It the transmitted intensity, and l the optical path length.  
τ = l-1ln(Io/It)    (Eqn. 3.1) 
3.1.4 Results and Discussion 
 
3.1.4.1 Particle Stability 
 
In colloidal systems, unless strategies are employed to stabilize the particles either 
electrostatically or sterically, there is a tendency for particles to aggregate due to attractive 
van der Waals forces.  This was observed when the particles were suspended in water, as 
they aggregated rapidly in the absence of stabilizer.  In order to hinder aggregation, 
increasing amounts of CTAB were added to the particle suspension.  Generally, as CTAB 
concentration increased, particle stability increased (Figure 3.4).  In this manner, it was 
possible to determine conditions for colloidal stability within the timeframe of the 
dielectrophoretic experiments.  Turbidity experiments showed that 1.0% (w/v) CTAB was 
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adequate to slow particle aggregation and sedimentation of all the particle sizes studied 
sufficiently for our purposes (~5-10 minutes) (Figure 3.5).  
 
 
Figure 3.4 Turbidity measurements on 5 mg/mL hexnut suspensions at three CTAB 





Figure 3.5 Turbidity curves for aqueous particle suspensions containing 1.0 wt% CTAB 
where A) 5 mg/mL hexnut suspension, B) 10 mg/mL rod suspension, C) 20 mg/mL disc 
suspension, and D) 10 mg/mL boomerang suspension. 
 
Observation by fluorescence microscopy revealed individually suspended particles, 
however, a small number of aggregates were observed in solution.  These aggregates could 
be caused by depletion interactions.  In these aggregates, the rods, hexnuts, and discs packed 
with their major axes parallel to one another.  These aggregates typically settled out of 
solution much faster than individual particles.  The trimethylolpropane ethoxylate triacrylate 
polymer used to synthesize the particles is denser than water with an estimated specific 
gravity of 1.2-1.3 at 25 oC, and, in general, the sedimentation rate for the particles depended 
on their size and shape: 40-50 minutes for the rods and hexnuts, 10-30 minutes for the 
boomerangs and discs.  In addition, the limited mobility of the aggregates affected their 
response to the applied AC field; this was especially prevalent for the larger particles.  
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However, because the number of aggregates was small in comparison to the number of free 
particles we chose to focus on the free particles. 
3.1.4.2 Particle Fabrication Results 
 
The resulting PRINT particles were uniform in size and shape and were relatively 
stable in aqueous solution containing CTAB.  The tops of the particles were flat while the 
bottoms of the particles were slightly concave due to a meniscus that was formed during the 
mold filling process.  Scanning electron microscopy (SEM) images of the particles are shown 
in Figure 3.6 with corresponding optical fluorescence images.  Particle sizes were calculated 
using PCI software with SEM images.  The sizes obtained by SEM were slightly smaller (< 5 
%) than the sizes of the mold.  This is a result of the cosolvent removal during the washing 
and drying process prior to imaging by SEM.  Particle surface area and volume were 
calculated using these values (Table 3.1). 
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Figure 3.6 Representative scanning electron micrograph and fluorescent images of A.) 2.5 x 
1 µm hexnut particles with 1 µm hole, B.) 1.6 x 1.6 x 5 µm trapezoidal particles, C.) 6.5 x 0.8 
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3.1.4.3 Particle Alignment and Crystallization Experimental Results 
 
Dielectrophoretic alignment of particles in solution occurred when a nonuniform AC 
field was applied across two planar electrodes (Figure 3.3).  As expected for positive 
dielectrophoresis, when the field is turned on, the particles become polarized and are directed 
towards the region with the highest field intensity – the glass region between the electrodes. 
During this step, particles experience a torque and are observed to reorient to a new stable 
position from their initial random orientation relative to the field.  This electroorientation 
results in the alignment of particles with their longest axis parallel to the applied field (θ = 
0°), consistent with observations made by others.47, 48  Additionally, in the majority of cases, 
the particles’ second major axis (if there was one) was perpendicular to the normal of the 
plane of the electrode (φ = 90°), or in other words, the particles laid flat on the surface of the 
glass electrode (Figure 3.7).  Once the particles aligned with the field, they began to link 
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together forming chains.  This phenomenon is thought to be due to the interactions between 
the dipoles induced in the particles.37  Chains formed rapidly (10-20 seconds) and continued 
to grow as long as the field was left on.  The speed of chaining appeared to be a function of 
the size of the particle with the smaller particles (hexnuts and rods) forming chains the fastest 
while the discs formed chains much slower and the boomerangs formed no discernable 
chains.  Large chains of particles then moved slowly towards each other and formed large 
crystalline structures.  If the AC field was removed after being applied for only a short period 
(10-20 seconds), particles returned to a random state.  However, if the field was applied for a 
longer period of time, aggregation and sedimentation of the particles began to take place.  
This trapped some particles in permanent chains while bound to the surface of the glass cell.  




Figure 3.7 Particle orientation in the electric field: θ is the angle between the major axis of 
the particle and the AC field, and φ is the angle between the major axis of the particle and the 









Hexnut shaped particles, the smallest of the four particles shapes, aligned rapidly with 
the applied field.  The principle axis of the hexnut particle was 2.9 µm from point-to-point 
(Table 3.1).  The particles initially formed chains in this fashion (Figure 3.8 A-B).  It was 
interesting to observe that the majority of hexnut chaining took on a slightly different 
conformation with the flat edges of the particles touching one another rather than just the 
tips, thus the second axis of the hexnuts (2.5 µm) was found to be aligned parallel to the 
applied field.  This effect is most likely driven by the need to maximize surface interactions.  
That is, it is more energetically favorable for the chains to undergo a slight modification from 
the most dielectrophoretically stable conformation to one that is slightly less favorable 
because of the stability gained from the dramatic increase in surface interactions.  Chains of 
hexnuts had two orientations.  The primary orientation, shown in Figure 3.9 A, was with the 
particles parallel to the AC field (θ = 0° for secondary axis) and perpendicular to the normal 
of the electrode plane (φ = 90°).  The second, and less common orientation was with particle 
chains parallel to the AC field and parallel to the normal of the electrode (φ = 0°).  While this 
chain orientation was regularly observed, the chains typically collapsed back into the plane of 
the electrode.  Over time, chains of hexnut particles moved towards each other and came into 





Figure 3.8 Representative fluorescence images of randomly dispersed A, C, E, G, and 
electrically aligned B, D, F, H particles with a 5 µm scale bar.  
 
Rod shaped particles, like the hexnut particles, responded rapidly to the 
dielectrophoretic force and aligned with their primary axis parallel to the AC field (Table 
3.1). As particles began to move through solution, some particles (9% ± 1%) were trapped 
perpendicular to the AC field (θ = 90°, φ = 90°).  Very few particles were observed with the 
long axis parallel to the normal of the electrode plane.  Long chains of the rods formed 
almost immediately parallel to the AC field (Figure 3.8 C-D).  As with the hexnuts, the 
chains of rods came together to form crystals.  Unlike the hexnuts, the rods formed a 
rectangular lattice (Figure 3.9 B).  It is interesting to note that in the absence of any defects 
(perpendicular particles) individual particles within adjacent chains came into registry with 
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one another in a smectic-like manner.  We believe this effect may be driven by the areas of 
high field intensity at the corners of the particles.   
The disc shaped particles rapidly settled out of solution and sat with their face flat on 
the glass surface in the absence of an AC field.  Once settled, the particles became difficult to 
move even at higher voltages.  The circular nature of the disc shaped particles gives them 
only one major axis (Table 3.1).  This is different from the particles mentioned above which 
both have at least two major axes that aligned with the applied field.  Alignment of the disc 
shaped particles manifested itself with the particles laying flat on the surface of the glass (θ = 
0°, φ = 90°).   In comparison to the smaller particles the discs slowly (30-60 seconds) formed 
short chains (Figure 3.8 E-F).  The chains had trouble moving and therefore crystallization 
was only observed a few times.  The crystals that formed were hexagonal close-packed in 




Figure 3.9 Fluorescence images of aligned particles with applied AC electric field.  5 µm 
scale bar. 
 
Boomerang shaped particles exhibited unique behavior in comparison to the other 
particle shapes.  Similar to the other shapes, boomerangs typically laid flat in the plane of the 
electrode (φ = 90°).   But unlike the other shapes, the boomerangs had no preferential 
orientation with respect to θ, which may be due to the symmetry in the particle shape (Table 
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3.1).  Interestingly, the few boomerangs that did stand straight up aligned with the applied 
AC field (θ = 0°, φ = 45°).  These particles eventually tipped and fell back into the plane of 
the electrode (φ = 90°).  Although the boomerangs did not align in the presence of an applied 
AC field, they did adopt a number of interesting orientations in clusters (Figure 3.9 D i-iv).  
These clusters eventually grew large enough that some directionality was observed in which 
the clusters were aligned with the applied field.  Rapid sedimentation coupled with the 
unique shape of the particles prevented large-scale crystallization.  
While the studies have focused primarily on crystallization of particles between the 
electrodes (see Figure 3.10 A-D for low magnification images of particle alignment), 
crystallization on the electrodes was also observed.  This type of crystallization was only 
observed for the hexnut shaped particles.  These particles formed small hexagonal close-
packed clusters that laid flat on the electrode surface.  A large portion of the individual 
hexnut particles found on the electrode were oriented perpendicular to the surface of the 
electrode but had no significant preference for orientation otherwise.  The rod and disc 
shaped particles did not form crystals but did orient themselves perpendicular to the plane of 
the electrode.  Boomerang shaped particles did not exhibit any preferential alignment or 







Figure 3.10 Low magnification fluorescence images of particle alignment in nonuniform AC 
electric field for (A) hexnut, (B) rod, (C) disc, and (D) boomerang shaped particle 
suspensions.  
 






Figure 3.11 Fluorescence images of hexnut (A) and rod shaped (B) particles with applied 
AC electrical field on the electrode. 5 µm scale bar. 
 
3.1.4.4 Dielectrophoresis Summary 
 
The ability to design and fabricate new particle shapes with tailored chemistries 
expands the possibilities for observing and characterizing novel particle assemblies, and for 
the design and synthesis of advanced composite materials with interesting nanostructures.  
We have introduced new organic particle geometries to the study of colloidal assemblies, and 
have demonstrated that these new shapes can influence interesting packing and 
crystallization behavior.  With the exception of the boomerang shaped particles, all particle 
shapes studied exhibited chaining behavior in the presence of the nonuniform AC electric 
field.  Moreover, our results are consistent with others, as the anisotropic particles 
preferentially align with their longest axes parallel to the field.  We observed different crystal 
structures when the chains assembled: hexagonal close packed for the hexnuts and discs, and 
rectangular for the rods.  Interestingly, even though the boomerangs did not align in chains in 
the field, regions of unique packing were observed.  Unfortunately, this particular series of 
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sizes and shapes did not enable us to make systematic quantitative comparisons between the 
various particle shapes with regard to their response times and relaxation times.  These 

























3.2 Fabrication and Magnetic Manipulation of Shape and Size Specific Magneto-
Polymer Composite Particles 
 
3.2.1 Introduction and motivation for the Fabrication of Magneto-Polymer Composite 
Particles 
 
The relentless drive towards processes that can fabricate uniform, multifunctional 
colloidal particles has been strongly influenced by increasingly complex applications in both 
life and materials sciences.  One approach to enhancing the properties of colloidal particles is 
through the use of nanocomposites, such as the incorporation of inorganic nanoparticles into 
a polymer colloidal particle.  In this way, properties specific to the inorganic component are 
conferred to the composite particle thereby imparting desirable properties to the particle.  
Magnetic nanoparticles are one such filler particle of great interest, and they are integral to 
numerous biological and electronic processes.  For example, magnetic particles have been 
used in different bioseparation techniques, for magnetically-induced hyperthermia of 
malignant tumors, as contrast enhancement agents for magnetic resonance imaging (MRI), 
and in tissue repair.52, 53  Magnetic particles can also play a role in the delivery of biologics, 
especially drugs54-56 and nucleic acids (magnetofection)57-59, as they can be manipulated via 
external fields to improve transport in biological systems.  In the materials science field, the 
directed assembly or the self-assembly of magnetic particles has been found to be 
exceedingly useful in the fabrication of photonic crystals60-62 and as nanowire contacts in 
electronic devices.63, 64  They are also used as device components in microfluidics.65-67  
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Additionally, there has been growing interest in the use of magnetic particles in the 
fabrication of nanomotors and nanomachines.68-71   
With the host of applications requiring tailored magnetic particles, and the even 
greater number of potential applications that have yet to be realized, synthetic processes that 
can generate particles with specific features that result in some set of desired functionality 
and properties are in demand. Magneto-polymer nanocomposite particles have been 
synthesized via various bottom-up methods, typically with spherical geometry.  The 
composite particles can have a random internal structure, a core-shell structure,72 an aligned 
chain structure61, or the composite particles can be Janus particles, with the magnetic 
nanoparticles concentrated on one side.73-76  The alignment of the magnetic nanoparticles 
within the composite particle plays an important role in the overall magnetic properties, and 
thus the behavior of such particles in the presence of an external magnetic field.  For 
example, Dyab et al.73 showed that aligning and concentrating magnetite nanoparticles in 
their microparticles resulted in a change from superparamagnetic behavior of the 
nanoparticles to ferromagnetic behavior of the composite microparticles; furthermore, for 
janus microparticles, the colloidal materials, exhibited zigzag chaining in an external 
magnetic field.  Shape control, beyond spheres, is very difficult with bottom-up approaches, 
and there are very few examples of uniform non-spherical composite particles synthesized 
via these routes.74, 77, 78  One morphology of particular interest to the drug delivery 
community is the wormlike particle shape.77-79  This structure is accessible via block 
copolymer micelle morphologies78 and aggregation strategies,77 though with these 
approaches there is a broad distribution in final composite particle size.   
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There are even fewer examples of magneto-polymer nanocomposite particles 
fabricated via top-down methods, and these have been mainly in microfluidic devices.28-31  
Two main advantages of top-down approaches are uniformity and shape control.  It is 
possible to fabricate anisotropically-shaped nanocomposite particles in microfluidic devices, 
such as disks, plugs and torroids,80, 81 in addition to spheres.  The nanocomposite particles 
can have a uniform distribution of the magnetic nanoparticles. Hwang et al.80 studied the 
effect of shape on the alignment of magneto-polymer composite particles with the magnetic 
nanoparticles uniformly distributed.  They found that unlike the spheres, disks and plugs 
exhibited a directional preference to an external magnetic field arising from their shape 
asymmetry.  Microfluidic devices can also be used to fabricate composite particles with 
anisotropically distributed magnetic nanoparticles.82  
This chapter details the fabrication of well-defined, shape-specific magneto-polymer 
nanocomposite particles using the top-down imprint lithography approach, Particle 
Replication in Nonwetting Templates (PRINT®).  The PRINT process has proved to be a 
versatile, scalable particle fabrication platform with exceptional tunability of particle 
characteristics – size, shape, modulus, composition, cargo, surface functionalization and 
chemical anisotropy.83  This chapter builds upon early work84 by incorporating 
superparamagnetic magnetite nanoparticles into PRINT polymer particles resulting in unique 
magneto-polymer composite particles in a range of shapes and sizes, from nanoworms to 
micron-sized boomerangs.  One important feature of the fabrication process is the ability to 
manipulate the magnetic cargo within the particle matrix prior to its polymerization.  In this 
way, the magnetite nanoparticle chains can be permanently aligned in different directions 
relative to the composite particle axis, which affects particle motion in response to external 
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magnetic fields.  Additionally, it is demonstrated that the PRINT magneto-polymer particles 
can be engineered to be steerable micromotors, via the anisotropic surface functionalization 
of platinum.  In the presence of the fuel, hydrogen peroxide (H2O2), chemical locomotion is 
achieved85 and the encapsulated magnetite then provides a means of remotely steering the 
motors, providing an attractive multifunctional approach to powering and controlling motion 
on the microscale.  
3.2.2 Fabrication of Magnetic Hydrogel Composites with Random and Linear Magnetic 
Domains 
 
3.2.2.1 General Particle Composition 
 
As mentioned earlier, composite particles were fabricated with some minor 
modifications using the standard PRINT technique that has been described in great detail 
elsewhere.35-38  Particles were primarily composed of PEG700diacrylate (Sigma).  Amine 
functionality was imparted through the incorporation of N-aminopropyl methacrylamide 
(APMA, Polysciences, Inc.).  A fluorescent tracer (fluorescein-o-acrylate, Sigma) was used 
to aid in microscopic characterization and particle tracking.  Finally, a photoinitiator 1-
hydroxycyclohexylphenyl ketone (HCPK, Sigma) was incorporated to facilitate radical 
polymerization of the pre-particle solution.  Particle details including composition and 
template size are provided in Table 3.2 and Figure 3.12 respectively.  
Table 3.2 Particle composition, patterned PFPE mold, and thin film attributes. 
 
Particle Composition 












Figure 3.12 Atomic force micrographs of rice (A), worm-like (B), block (C), and 
boomerang-shaped (D) particles bound to a sacrificial adhesive layer of poly(cyanoacrylate). 
 
3.2.2.2 Nano-scale Particle Fabrication 
 
For particles with a critical dimension measuring 80 nm (80 x 360 nm “rice” and 80 x 
2000 nm “worms”), the monomer solution was diluted with dimethylformamide (DMF) after 
which an aliquot of dextran-stabilized iron oxide (~20 nm Fe3O4) nanocrystals (FluidMag 
DX, Chemicell GmBH) was added.  The thin film (~2.5 µm) was cast over a sheet of 
poly(ethylene terephthalate) (PET) using a Mayer rod (2.5 µm feature size RD Specialties, 
Inc.).  After a brief drying period (22 °C) to remove excess DMF, the thin film was laminated 
to, and immediately split from, a patterned perfluoropolyether (PFPE, Fluorocur®, Liquidia 
Technologies, Inc.) mold (Lot # MC1-0175-131), thus filling the cavities of the mold with a 
pre-particle suspension.  Next, a second sheet of PET was laminated to the surface of the 
filled mold that was then placed in a UV curing chamber.  After curing (~12 J/cm2, 365 nm), 
particles adhered to the PET sheet as it was split from the mold (see Figure 3.13 A and C).  
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Particles were then removed from the PET by spreading 400 uL of distilled water over the 
surface and gently agitating the particles with a rubber cell scraper.  The particles were then 
rinsed with Milli-Q water to remove any sol fraction and non-magnetic debris using a 
magnetic column (MiniMacs, Miltenyi Biotec).  TEM images of the worm-like and rice 
nanoparticles (Figure 3.13 B and D) show the successful loading of Fe3O4.  In addition, there 
was a fairly uniform distribution of the Fe3O4 nanoparticles within the polymer matrix.  
These particles represent the first published examples of shape and size specific magneto-
polymer composite nanoparticles fabricated by a top-down method.  Given the shape and size 
control, these composite nanoparticles are very promising candidates for different life science 
applications.   
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Figure 3.13 SEM (A) and TEM (B) of 80 x 2000 nm “worm-like” particles and SEM (C) and 
TEM (D) of 80 x 360 nm “rice” particles show the nanoscale particles in an array on a PET 
harvesting layer and cast from solution onto a TEM grid.  Scale bars are 3 µm (A), 80 nm 
(B), 2 µm (C), and 70 nm (D). 
3.2.2.3 Micro-scale Particle Fabrication 
For the micron-sized particles, the Fe3O4 nanoparticles used were uncoated 200 nm 
iron oxide (Polysciences, Inc.) instead of the 20 nm surface coated variety.  The larger iron 
oxide particles were used both because they provided stronger magnetic characteristics and 
because the mold feature sizes were large enough to accommodate the increased iron oxide 
crystal size.  The nanoparticles were stabilized in 1% pluronic solution prior to combining 
with the monomers.  For all experiments, the composite particles were charged with 10 wt% 
Fe3O4, though it was possible with this process to vary the Fe3O4 content up to 50 wt% (see 
Figure 3.14).  The pre-particle suspension films were cast from a neat solution and fabricated 
using a similar technique described in previous work.86  Rhombohedral (block-shaped) and 
boomerang-shaped particles were centrifuged and washed first with acetone 5 times to 
remove residual adhesive then transferred to Milli-Q water for improved stability and 
handling.   
 
Figure 3.14 Fluorescent micrograph of particles containing 1, 10, and 50 wt % magnetite 
particles.  The composite particles are trapped in a patterned PFPE mold.  Small clusters of 
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magnetite are visible in the 1 and 10 wt % particles as dark spots in the green fluorescent 
polymer background. 
Overall composite particle shape has been shown to dictate the direction of the 
particle’s magnetic moment.80  Using the template-based PRINT method, the magnetic 
moment was dictated by the net magnetic moment of the magnetite clusters within the 
composite particle.  Alignment of magnetic nanocrystals within the polymer-composite was 
possible due to the unique top-down approach to particle fabrication (See Figure 3.15).  If 
alignment of the Fe3O4 was desired, prior to curing, the filled PFPE mold was placed 
between two neodymium magnets (5,233 Gauss each) separated by one inch for at least 2 
minutes.  During this time, the Fe3O4 nanocrystals formed linear aggregates parallel to the 
applied field.  Directionality of the Fe3O4 chains, with respect to the polymer composite 
particle, was controlled by changing the orientation of the mold in the magnetic field.   As 
such, a wide variety of magnetic configurations were possible, thus demonstrating the fact 
that the orientation of the magnetic moment of the composite particles was independent of 
the overall particle shape.  Next, the mold and magnets were placed in a UV curing chamber 
that was purged with nitrogen gas.  The particles were then cured as described earlier.  
 
 
Figure 3.15 A schematic representation of the PRINT process wherein the PFPE mold 
(shown in green) (A) and pre-particle solution (shown in red) containing randomly dispersed 
Fe3O4 is placed in a magnetic field (B) created by two permanent magnets (i).  Linear 
aggregates of Fe3O4 (ii) are formed prior to photopolymerization (iii) of the composite 
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particle.  After harvesting and purification linear aggregates of Fe3O4 are clearly visible via 
the ESEM backscattered electron detector (C).  Scale bar is 10 µm. 
3.2.2.4 Directionality of Linear Chains of Magnetite 
 
Directionality of the linear Fe3O4 aggregates, examined by fluorescence microscopy, 
is demonstrated in Figure 3.15.  Boomerang particles were cured with the no applied field, a 
field normal to the plane of the particles, at 45° to both arms of, and parallel to one arm of 
the particle.  Rhombohedral particles were cured with the field perpendicular to and parallel 
to the length of the particle.  In Figure 3.14, the dark regions void of fluorescence within the 
green polymer matrix clearly indicate the presence of Fe3O4 nanoparticles.  It was found that 
when there was no applied magnetic field during curing, the composite particles were not 
homogeneous - the Fe3O4 nanoparticles form small random aggregates within the particles 
(Figure 3.16 A).  This may be because the nanoparticles were not well-stabilized in the 
monomer solution.  The use of particles stabilized with a suitable organic coating would most 
likely improve the homogeneity of the composite particles.  When the particles were cured in 
the presence of an applied field, linear aggregates of Fe3O4 were trapped in specific 
directions within the micron-sized particles (Figure 3.16 B-F).  Alignment of Fe3O4 within 
the rice and worm-like particles was difficult to obtain because highly defined linear 




Figure 3.16 Fluorescence microscopy images of 10 µm boomerang-shaped particles trapped 
in the patterned PFPE mold with no linear Fe3O4 aggregates (A), aggregates normal to the 
plane of the particle (B), aggregates parallel to the plane at a 45o angle to the arms of the 
boomerang (C), and aggregates parallel to one arm of the boomerang (D).  Harvested block-
shaped 2 x 2 x 6 µm  particles with linear aggregates perpendicular to the length of the 
particles (E) and parallel to the length of the particles (F).  Scale bars are all 10 µm. 
 
3.2.3 Magnetic Manipulation of Microscale Composite Particles 
 
 121	  
Rhombohedral and boomerang-shaped composite particles were then dispersed in 
water (φ = 0.0001).  In the absence of a magnetic field, the composite particles had no 
preferred orientation.  Once placed in a magnetic field between two identical similarly 
oriented permanent magnets, the composite particles aligned with the field according to the 
direction of their highest magnetic moment.  Composite particles with linear Fe3O4 
aggregates all aligned with the field in one orientation and followed changes in the magnetic 
field as it was rotated around the microscope stage.  Composite particles with randomly 
dispersed Fe3O4 also changed orientation with the applied magnetic field but were not in 
registration with one another.  Movies of boomerang-shaped particles show how the particles 
preferentially orient themselves with respect to their magnetic poles in a rotating magnetic 
field.  Boomerang-shaped particles with linear Fe3O4 aggregates parallel to the plane of the 
particle are shown to rotate while laying flat.  By comparison, particles with linear Fe3O4 
aggregates normal to the plane of the particle stand up right while rotating with the external 
magnetic field. 
Magnetic alignment of the composite particles was achieved at higher concentrations 
(φ = 0.001 – 0.005).  As before, the composite particles aligned with their highest magnetic 
moment parallel to direction of the applied magnetic field.  In this case however, the high 
concentration made it possible for chaining to occur.  Based on the directionality of the linear 
Fe3O4 aggregates, chaining of 2 x 2 x 6 µm rhombohedral particles was observed in three 
distinct manifestations demonstrated in Figure 3.17.  Samples with aggregates aligned with 
the long axis of the particle formed chains with all of the particles in line with the applied 
magnetic field.  Samples with the linear Fe3O4 aggregates aligned along the short axis of the 
particle formed chains of stacked composite particles.  Finally, samples in which the 
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magnetite was not aligned showed chaining with no specific orientation of the composite 
particles.  Once the field was removed, the chains of composite particles fell apart without 
the need for external agitation or de-Gaussing.  SQUID (Superconducting Quantum 
Interference Device) magnetometry confirmed that particles were superparamagnetic in 
behavior (Figure 3.18).   
 
Figure 3.17 Fluorescence microscopy images of a dispersion of block-shaped 2 x 2 x 6 µm 
composite particles in the absence of an applied magnetic field (A).  Particles without linear 
aggregates (B) in an applied magnetic field formed disordered chains, while particles with 
linear aggregates parallel to (C) and perpendicular to (D) the length of the composite particle 
formed organized chains stacking head-to-tail and side-to-side respectively.  Insets for B, C, 
and D are cartoons that reflect particle alignment representative of each of the three types of 





Figure 3.18 Magnetization curves for 2 × 2 × 6 µm3 rhombohedral particles with dispersed 
Fe3O4 and linear aggregates of Fe3O4 aligned perpendicular and parallel to the length of the 
particles. All magnetic orientations exhibit superparamagnetic behavior.  
 
3.2.4 End-labeled Composite Particles and Their Use as Micromotors 
 
3.2.4.1 End-labeling Composite Particles 
 
Using a series of rhombohedral PRINT particles with 2 × 2 µm2 square cross-
sections, the potential for PRINT particles as engineered micromotors was explored.  Three 
aspect ratios were used: 0.5, 2 and 3, and all of the particles contained 10 wt % Fe3O4 aligned 
parallel to the height of the particles (perpendicular to the plane of the mold).  Two strategies 
were employed to regiospecifically functionalize the particles: chemical grafting and metal 
deposition.87  After photocuring the particles, but while still in the mold, a reactive dye, 
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Dylight 549-NHS (Fisher Scientific), was grafted onto the exposed face of the particles using 
the reactive amine groups in the particle matrix.  Three nanometers of titanium (Ti) followed 
by 20 nm platinum (Pt) were evaporated onto the full mold of particles.  The particles were 
then harvested from the mold using poly(cyanoacrylate).  Following this, the particles were 
washed multiple times in acetone and collected in distilled water.  It was also possible to put 
the dye and the metal on opposite faces of the particles. To do so, the particles were 
poly(cyanoacrylate)-harvested after reacting the dye to the exposed face of the particles, then 
the Ti and Pt were evaporated on the particles in the harvested array, where the opposite side 
of the particles were exposed.  The particles were then washed and collected as described 
above.  Both approaches were equally effective at anisotropically surface functionalizing the 
particles.  Figure 3.19 demonstrates the successful end-functionalization of a 2 × 2 × 4 µm3 
particle.  The Energy Dispersive Spectroscopy (EDS) elemental line scan in Figure 3.19 




Figure 3.19 SEM image (A) of a Pt-capped 2 x 2 x 4 µm3 PRINT particle containing linear 
aggregates of Fe3O4 with elemental line scan (magenta) indicating the location of the iron 
(red) and platinum (teal) in the particle. Scale bar is 2 µm.  Traces of 2 x 2 x 4 µm3 particles 
(C) in 10% in a stationary (dotted) and rotating (solid) magnetic field H2O2. 	  
3.2.4.1 Background of Micromotor Particles in H2O2  
 
 The Pt-capped, magneto-polymer PRINT particles were studied in the presence of 
hydrogen peroxide (H2O2).  It is well known that Pt catalyzes the decomposition of H2O2 to 
water and oxygen.  This reaction has been exploited to power the motion of nano- and 
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microobjects in solution, though there is some dispute as to the mechanism of motion, 
whether due to bubble formation88 or self-diffusiophoresis89.  Despite this ambiguity, it was 
observed that the Pt-capped, magneto-polymer PRINT particles were definitely motile in 
H2O2 solution.  Moreover, it was found that the motion was linear and directed away from 
the Pt end of the particle.  Similar to the boomerang-shaped particles described above, Fe3O4 
present in the Pt-endcapped particles provided a mechanism for changing the direction of 
particles in solution.  The direction of a 2 × 2 × 6 µm3 particle, containing magnetite chained 
along the long axis of the rod, was changed by moving a strong permanent magnet around 
the microscope stage (see Figure 3.20).  The particle responded immediately to the change in 
position of the magnet, and thus was able to be steered accurately.  A movie of the steered 
motion of a 2 × 2 × 6 µm3 rod was converted to a schematic (see Figure 3.21).  The dye was 
placed on the same end of the particle as the Pt to clearly illustrate that the motion is directed 





Figure 3.20 Schematic of an in-house magnetic stage for particle rotation and alignment 
experiments in water.  The runner (gray) rotates in a circular fashion (green double-sided 
arrow) around the magnetic particle sample (red and gray) in the center of the microscope 
stage (purple).  Magnets at opposite ends of the runner (blue) with similarly facing magnetic 






Figure 3.21 Schematic representation of a movie of one microscale rocket particle in 10 % 
H2O2.  The particle moves through space in a linear fashion parallel to the direction of the 
applied magnetic field (B).  Once the direction of B is changed the particle changes direction.   
 
3.2.4.2 Micromotor Particles in H2O2 in a Stationary Magnetic Field 
 
Particle motion was observed as a function of particle aspect ratio (0.5, 2, 3) and 
H2O2 concentration (0%, 10%, 20%, 30%).  The particles were tracked in the presence of a 
stationary or rotating magnet; due to the microscope configuration, the magnet was located 
off-center above the solution.  Figure 3.22 offers a schematic description of microscope and 
magnetic setup for these experiments.  For the stationary magnet experiments, at 0% H2O2, 
all of the particles exhibited small random movements due to Brownian motion. With 
 129	  
increasing H2O2 concentration, the particles were propelled linearly through solution, and for 
each particle aspect ratio, the particle velocities were the same (within error, Table 3.2) with 
increasing H2O2 concentrations.  The highest particle velocities were observed with the 2 × 2 
× 4 µm3, at speeds as high as 6 µm/s.  It was expected that the smallest particle, the 2 × 2 × 1 
µm3 square discs, would be the fastest, however, they appeared to move slower than the 2 × 2 
× 4 µm3 rods.  This may be because the motion of the disks was somewhat irregular, and they 
tended to change direction fairly readily, unlike the more elongated particles.  The 2 × 2 × 6 





Figure 3.22 The above figure is a schematic of the microscope-sample-rotating magnet 
setup. The magnet is mounted on a motor and is suspended above the sample, slightly off-
center from the path of the transmitted light. 
 
Table 3.3 Particle translational velocities for all particle sizes under a stationary magnetic 




%	  H2O2	   Average	  Translational	  
Velocity	  (µm/s)	  
Standard	  error	  2x2x1	   0	   0.25	   0.07	  2x2x1	   10	   28.49	   10.76	  2x2x1	   20	   22.14	   7.83	  2x2x1	   30	   27.29	   12.21	  2x2x4	   0	   0.21	   0.06	  2x2x4	   10	   54.88	   12.94	  2x2x4	   20	   47.30	   21.15	  2x2x4	   30	   56.97	   28.49	  2x2x6	   0	   0.93	   0.19	  2x2x6	   10	   22.62	   5.84	  2x2x6	   20	   16.33	   8.17	  2x2x6	   30	   22.96	   13.25	  
 
3.2.4.2 Micromotor Particles in H2O2 in a Rotating Magnetic Field 
 
For the rotating magnet experiments, at 0 % H2O2 the particles rotated at the same 
speed as the magnet about their axes with no lateral motion.  In the presence of H2O2, a very 
unusual type of particle motion was observed.  All of the particles tended to travel a prolate 
cycloid path.  The particle tracks for both the stationary and rotating magnet experiments are 
presented in Figure 3.18 C.  This unique motion occurred because the particles were 
experiencing both a linear force due to H2O2 decomposition as well as the torque from the 
rotating magnet located off to one side of the solution.  In addition, the particle velocities 
were found to be significantly slower than in the presence of the stationary magnet.   
3.2.5 Magneto-Polymer Composites Summary 
 
The development of magneto-polymer composite nanoscale and microscale particles 
has potential for a number of new biomedical and materials-based applications.  Using the 
PRINT technique, we have shown fabrication of such particles with highly tailored form 
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factors ranging in size from 50 nm to 10 µm.  The microscale composite particles were 
fabricated with a variety of different magnetic conformations with respect to the overall 
particle dimensions.  We have shown the manipulation of these particles in solution using 
applied magnetic fields.  We also demonstrated regiospecific functionalization of these 
particles with amine reactive organic dyes and deposited platinum for use as self-propelled 
micromotors in H2O2.  These experiments clearly demonstrate our ability to manipulate the 
motion of catalytically-driven magneto-polymer PRINT particles.  Smaller and more highly 
magnetic nanocomposites are currently being examined.  We hope that this work will open 
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